BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zeng H, Chen W, Zheng R, Zhang S, Ji JS, Zou X, Xia C, Sun K, Yang Z, Li H, Wang N, Han R, Liu S, Mu H, He Y, Xu Y, Fu Z, Zhou Y, Jiang J, Yang Y, Chen J, Wei K, Fan D, Wang J, Fu F, Zhao D, Song G, Jiang C, Zhou X, Gu X, Jin F, Li Q, Li Y, Wu T, Yan C, Dong J, Hua Z, Baade P, Bray F, Jemal A, Yu XQ, He J. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries. Lancet Glob Health. 2018;6:e555-e567. [PMID: 29653628 DOI: 10.1016/s2214-109x(18)30127-x] [Cited by in Crossref: 467] [Cited by in F6Publishing: 534] [Article Influence: 93.4] [Reference Citation Analysis]
Number Citing Articles
1 Xu WF, Yang P, Wei ZW, Liu JS, Yan RL, Chen Q, Tong RX, Xu SY, Gao WQ, Zhang W, Chang ZZ, Wang PL, Fang HJ, Zheng YY, Wang T, Liu NN, Yao C, Liu YL, Xia W, Zhao W, Wang ZJ. Correlation between the Human Development Index and the Incidence and Mortality of Non-Hodgkin Lymphoma. Curr Med Sci 2023. [PMID: 36943542 DOI: 10.1007/s11596-022-2682-5] [Reference Citation Analysis]
2 Chen Y, Chen T, Fang JY. Burden of gastrointestinal cancers in China from 1990 to 2019 and projection through 2029. Cancer Lett 2023;:216127. [PMID: 36933779 DOI: 10.1016/j.canlet.2023.216127] [Reference Citation Analysis]
3 Han Y, Zhu X, Hu Y, Yu C, Guo Y, Hang D, Pang Y, Pei P, Ma H, Sun D, Yang L, Chen Y, Du H, Yu M, Chen J, Chen Z, Huo D, Jin G, Lv J, Hu Z, Shen H, Li L. Electronic Health Record-Based Absolute Risk Prediction Model for Esophageal Cancer in the Chinese Population: Model Development and External Validation. JMIR Public Health Surveill 2023;9:e43725. [PMID: 36781293 DOI: 10.2196/43725] [Reference Citation Analysis]
4 Gao Y, Xin L, Lin H, Yao B, Zhang T, Zhou AJ, Huang S, Wang JH, Feng YD, Yao SH, Guo Y, Dang T, Meng XM, Yang ZZ, Jia WQ, Pang HF, Tian XJ, Deng B, Wang JP, Fan WC, Wang J, Shi LH, Yang GY, Sun C, Wang W, Zang JC, Li SY, Shi RH, Li ZS, Wang LW. Machine learning-based automated sponge cytology for screening of oesophageal squamous cell carcinoma and adenocarcinoma of the oesophagogastric junction: a nationwide, multicohort, prospective study. Lancet Gastroenterol Hepatol 2023:S2468-1253(23)00004-3. [PMID: 36931287 DOI: 10.1016/S2468-1253(23)00004-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Yang J, Shi Z, Zhang X, Liu Q, Cui X, Li L, Liu B, Wei J. Real-world clinical outcomes of the combination of anti-PD-1 antibody, trastuzumab, and chemotherapy for HER2-positive gastric/gastroesophageal junction cancer. Cancer Med 2023. [PMID: 36912199 DOI: 10.1002/cam4.5722] [Reference Citation Analysis]
6 Wang Q, Zhang X, Zhong Y, Wei S, Li L, Wei W, Liu F, Li Y, Wang S. Clinical characteristics and changing trajectories of esophageal cancer and gastric cancer in China from 2010 to 2019: An analysis of a hospital-based database of 24,327 patients. Front Oncol 2023;13. [DOI: 10.3389/fonc.2023.1126841] [Reference Citation Analysis]
7 Jiang R, Sun Y, Li Y, Tang X, Hui B, Ma S, Zhang J, Sun C, Tan J, Zhou B, Lei J, Jiang T. Cuproptosis-related gene PDHX and heat stress-related HSPD1 as potential key drivers associated with cell stemness, aberrant metabolism and immunosuppression in esophageal carcinoma. Int Immunopharmacol 2023;117:109942. [PMID: 36889194 DOI: 10.1016/j.intimp.2023.109942] [Reference Citation Analysis]
8 Hu K, Zheng QM, Wang YP, Zhao MM, Sun ZG. Clinical and prognostic features of E-cadherin in adenocarcinoma of the esophagogastric junction patients. Eur J Cancer Prev 2023;32:119-25. [PMID: 36484275 DOI: 10.1097/CEJ.0000000000000776] [Reference Citation Analysis]
9 Sun W, Lei X, Lu Q, Wu Q, Ma Q, Huang D, Zhang Y. LncRNA FRMD6-AS1 promotes hepatocellular carcinoma cell migration and stemness by regulating SENP1/HIF-1α axis. Pathol Res Pract 2023;243:154377. [PMID: 36827886 DOI: 10.1016/j.prp.2023.154377] [Reference Citation Analysis]
10 Zhu J, Ma S, Chen R, Xie S, Liu Z, Liu Z, Wei W. Long-term anxiety and depression signatures of participants that received esophageal cancer screening: A multicenter population-based cohort study. Cancer Med 2023;12:6294-306. [PMID: 36420699 DOI: 10.1002/cam4.5404] [Reference Citation Analysis]
11 Niu PH, Zhao LL, Wang WQ, Zhang XJ, Li ZF, Luan XY, Chen YT. Survival benefit of younger gastric cancer patients in China and the United States: A comparative study. World J Gastroenterol 2023; 29(6): 1090-1108 [DOI: 10.3748/wjg.v29.i6.1090] [Reference Citation Analysis]
12 Zhao X, Guo M, Zhu S, Zhang L, Dong T, Luo H, Yu W, Zhu J, Fan X, Han Y, Liu Z. Pre-procedure oral administration of pronase improves efficacy of lugol chromoendoscopy in esophageal squamous cell carcinoma screening: a prospective, double-blinded, randomized, controlled trial. Surg Endosc 2023. [PMID: 36781469 DOI: 10.1007/s00464-023-09902-1] [Reference Citation Analysis]
13 Zhang X, Zhou H, Ma Y, Liu K, Chen B. Identification of ferroptosis signature genes in hepatocellular carcinoma and renal clear cell carcinoma.. [DOI: 10.21203/rs.3.rs-2439315/v1] [Reference Citation Analysis]
14 Xinran Z, Shumei Z, Xueying Z, Linan W, Ying G, Peng W, Yahong H, Longting M, Jing W. Construction of a predictive model for cognitive impairment risk in patients with advanced cancer. Int J Nurs Pract 2023;:e13140. [PMID: 36759715 DOI: 10.1111/ijn.13140] [Reference Citation Analysis]
15 Yan R, Wang J, Yu J. Association of sexual attitudes with sexual dysfunction and sexual distress among Chinese breast cancer survivors: a cross-sectional study. Support Care Cancer 2023;31:154. [PMID: 36757498 DOI: 10.1007/s00520-023-07600-1] [Reference Citation Analysis]
16 Huang L, Lu J, Shi L, Zhang H. Regulation, production and clinical application of Foods for Special Medical Purposes (FSMPs) in China and relevant application of food hydrocolloids in dysphagia therapy. Food Hydrocolloids 2023. [DOI: 10.1016/j.foodhyd.2023.108613] [Reference Citation Analysis]
17 Xiao D, Yan C, Li D, Xi T, Liu X, Zhu D, Huang G, Xu J, He Z, Wu A, Ma C, Long J, Shu K, Ji H, Wang N, Chen G, Yang J, Ma H, Li Z, Sun X, Qu Y, Liu Z, Jiang X, Tian C, Ni S, Zhan R, Chen L, Ge M, Wang M, Jiang X, Guo G, Han Z, Zhang C, Zhang T, Dou C, Chu L, Wang P, Shao J, Wu X, Yu J, Wang Y, Wu N, Zhang R, Zhang M, Hong Y, Gao J, Li Y, Pan Y, Zhao B, Ji N, Shan G, Patel CB, Jia W, Zhang L. National Brain Tumour Registry of China (NBTRC) statistical report of primary brain tumours diagnosed in China in years 2019–2020. The Lancet Regional Health - Western Pacific 2023. [DOI: 10.1016/j.lanwpc.2023.100715] [Reference Citation Analysis]
18 Pan S, Cao M, Hu C, Zhang Y, Du Y, Xu Z, Cheng X. A Novel Method for Dynamically Assessing the Prognosis of Patients with pT1 Gastric Cancer: A Large Population-Based Dynamic Prognostic Analysis. J Oncol 2023;2023:8629166. [PMID: 36747903 DOI: 10.1155/2023/8629166] [Reference Citation Analysis]
19 Liu M, Zhang Z, Zhang W, Liu SM. Advances in biomarker discovery using circulating cell-free DNA for early detection of hepatocellular carcinoma. WIREs Mech Dis 2023;:e1598. [PMID: 36697374 DOI: 10.1002/wsbm.1598] [Reference Citation Analysis]
20 Liu J, Wang Y, Zhao Z, Ge Y. High expression of PPIA associates with poor prognosis and tumor immune infiltration of gastric cancer.. [DOI: 10.21203/rs.3.rs-2498288/v1] [Reference Citation Analysis]
21 Zhang P, Zhao JH, Chen L, Bian ZL, Ju LL, Wang HX, Cai WH. Expression and function of myelin expression factor 2 in hepatocellular carcinoma. BMC Gastroenterol 2023;23:20. [PMID: 36658471 DOI: 10.1186/s12876-023-02644-3] [Reference Citation Analysis]
22 Su B, Zhong P, Xuan Y, Xie J, Wu Y, Chen C, Zhao Y, Shen X, Zheng X. Changing Patterns in Cancer Mortality from 1987 to 2020 in China. Cancers (Basel) 2023;15. [PMID: 36672425 DOI: 10.3390/cancers15020476] [Reference Citation Analysis]
23 Zhao Y, Yang D, Yan Y, Zhang X, Yang N, Guo Y, Yu C. Secular Trends of Liver Cancer Mortality and Years of Life Lost in Wuhan, China 2010-2019. Curr Oncol 2023;30:938-48. [PMID: 36661720 DOI: 10.3390/curroncol30010071] [Reference Citation Analysis]
24 Guo L, Meng Q, Zheng L, Chen Q, Liu Y, Xu H, Kang R, Zhang L, Liu S, Sun X, Zhang S. Lung Cancer Risk Prediction Nomogram in Nonsmoking Chinese Women: Retrospective Cross-sectional Cohort Study. JMIR Public Health Surveill 2023;9:e41640. [PMID: 36607729 DOI: 10.2196/41640] [Reference Citation Analysis]
25 Wang Y, Zhao C, Ma P, Jiang D. Outcome and Cost-Effectiveness Analysis of Long-acting G-CSF as Primary Prophylaxis of Neutropenia Induced by Chemotherapy in Breast Cancer Patients, From a Retrospective Study. Cancer Control 2023;30:10732748221140289. [PMID: 36598048 DOI: 10.1177/10732748221140289] [Reference Citation Analysis]
26 Xi C, Shen JJ, Burston B, Upadhyay S, Zhou S. Epidemiological/Disease and Economic Burdens of Cervical Cancer in 2010-2014: Are Younger Women at Risk? Healthcare (Basel) 2023;11. [PMID: 36611604 DOI: 10.3390/healthcare11010144] [Reference Citation Analysis]
27 Hu D, Zhang H, Wang L, Liu W, Yang X, Li J. Research on return to work for colorectal cancer survivors: A bibliometric analysis.. [DOI: 10.21203/rs.3.rs-2408929/v1] [Reference Citation Analysis]
28 Shan T, Ran X, Li H, Feng G, Zhang S, Zhang X, Zhang L, Lu L, An L, Fu R, Sun K, Wang S, Chen R, Li L, Chen W, Wei W, Zeng H, He J. Disparities in stage at diagnosis for liver cancer in China. Journal of the National Cancer Center 2023. [DOI: 10.1016/j.jncc.2022.12.002] [Reference Citation Analysis]
29 Liang L, Wang X, Huang S, Chen Y, Zhang P, Li L, Cui Y. Tyrosine kinase inhibitors as potential sensitizers of adoptive T cell therapy for hepatocellular carcinoma. Front Immunol 2023;14:1046771. [PMID: 36936932 DOI: 10.3389/fimmu.2023.1046771] [Reference Citation Analysis]
30 Sun C, Li M, Lan L, Pei L, Zhang Y, Tan G, Zhang Z, Huang Y. Prediction models for chronic postsurgical pain in patients with breast cancer based on machine learning approaches. Front Oncol 2023;13:1096468. [PMID: 36923433 DOI: 10.3389/fonc.2023.1096468] [Reference Citation Analysis]
31 黄 东. Expression of RBM3 in Non-Small Cell Lung Cancer and Its Correlation with Prognosis of Patients. ACM 2023;13:3088-3103. [DOI: 10.12677/acm.2023.133440] [Reference Citation Analysis]
32 Fang C, Luo R, Zhang Y, Wang J, Feng K, Liu S, Chen C, Yao R, Shi H, Zhong C. Hepatectomy versus transcatheter arterial chemoembolization for resectable BCLC stage A/B hepatocellular carcinoma beyond Milan criteria: A randomized clinical trial. Front Oncol 2023;13:1101162. [PMID: 36923427 DOI: 10.3389/fonc.2023.1101162] [Reference Citation Analysis]
33 何 伟. Progress in Prevention and Treatment of Organ Fibrosis by Turtle Shell and Its Compound Preparation. ACM 2023;13:349-355. [DOI: 10.12677/acm.2023.131053] [Reference Citation Analysis]
34 Chen R, Zheng R, Zhang S, Wang S, Sun K, Zeng H, Li L, Wei W, He J. Patterns and trends in esophageal cancer incidence and mortality in China: an analysis based on cancer registry data. Journal of the National Cancer Center 2023. [DOI: 10.1016/j.jncc.2023.01.002] [Reference Citation Analysis]
35 Shi Y. Landscape of the clinical development of China innovative anti-lung cancer drugs. Cancer Pathogenesis and Therapy 2023;1:67-75. [DOI: 10.1016/j.cpt.2022.10.003] [Reference Citation Analysis]
36 周 积. The Potential Clue for Early Diagnosis of Pancreatic Cancer—New-Onset Diabetes. ACM 2023;13:3766-3773. [DOI: 10.12677/acm.2023.133540] [Reference Citation Analysis]
37 Zhang B, Tao B, Li Y, Yi C, Lin Z, Ma Y, Han J, Shao W, Chen Z, Lin J, Chen J. Dual immune checkpoint inhibitors or combined with anti-VEGF agents in advanced, unresectable hepatocellular carcinoma. Eur J Intern Med 2022:S0953-6205(22)00454-X. [PMID: 36588054 DOI: 10.1016/j.ejim.2022.12.025] [Reference Citation Analysis]
38 Wu H, Xiong F, Bao X, Lu J. Immune checkpoint blockade PD-1 therapy for primary liver cancer: incidence and influencing factors of thyroid dysfunction. Infect Agent Cancer 2022;17:64. [PMID: 36581947 DOI: 10.1186/s13027-022-00476-6] [Reference Citation Analysis]
39 Shi X, Liu X, Huang S, Hao Y, Pan S, Ke Y, Guo W, Wang Y, Ma H. miR-4443 promotes radiation resistance of esophageal squamous cell carcinoma via targeting PTPRJ. J Transl Med 2022;20:626. [PMID: 36578050 DOI: 10.1186/s12967-022-03818-5] [Reference Citation Analysis]
40 Yu Zhang, Jidong Wang, Di Cui, Lei Kong, Peng Wang, Zhixue Fu, Mengmeng Su, Bin Li, Jun Liang. Safety and efficacy analysis of chemoradiotherapy/radiotherapy combined with nimotuzumab for treating unresectable oesophageal squamous cell carcinoma in elderly patients: a retrospective analysis. BMC Gastroenterol 2022;22:526. [PMID: 36528571 DOI: 10.1186/s12876-022-02602-5] [Reference Citation Analysis]
41 Li H, Zhang H, Zhang H, Wang Y, Wang X, Hou H; Global Health Epidemiology Reference Group. Survival of gastric cancer in China from 2000 to 2022: A nationwide systematic review of hospital-based studies. J Glob Health 2022;12:11014. [PMID: 36527356 DOI: 10.7189/jogh.12.11014] [Reference Citation Analysis]
42 Tang WZ, Yusuf A, Jia K, Iskandar YHP, Mangantig E, Mo XS, Wei TF, Cheng SL. Correlates of stigma for patients with breast cancer: a systematic review and meta-analysis. Support Care Cancer 2022;31:55. [PMID: 36526859 DOI: 10.1007/s00520-022-07506-4] [Reference Citation Analysis]
43 Wang Z, Wang L, Wang S, Xie L. Burden of kidney cancer and attributed risk factors in China from 1990 to 2019. Front Public Health 2022;10:1062504. [PMID: 36589951 DOI: 10.3389/fpubh.2022.1062504] [Reference Citation Analysis]
44 Li K, Wang S, Li N, Zhao W, He N, Wang J, Ji K, Zhang M, Song H, Liu Q, Du L. Prognostic Biomarkers after Radiotherapy for Nonsmall Cell Lung Cancer Based on Bioinformatics Analysis. Biomed Res Int 2022;2022:6405228. [PMID: 36567906 DOI: 10.1155/2022/6405228] [Reference Citation Analysis]
45 Kang Wang, Hong-Ming Yu, Yan-Jun Xiang, Yu-Qiang Cheng, Qian-Zhi Ni, Wei-Xing Guo, Jie Shi, Shuang Feng, Jian Zhai, Shu-Qun Cheng. Efficacy and safety of radiotherapy combined with atezolizumab plus bevacizumab in treating hepatocellular carcinoma with portal vein tumour thrombus: a study protocol. BMJ Open 2022;12:e064688. [PMID: 36521893 DOI: 10.1136/bmjopen-2022-064688] [Reference Citation Analysis]
46 Li R, Zheng Y, Huang J, Lei H, Xu M, Wang L, Zhang L, Cheng Y, Jiang X, Tang H, Shi Z, Chen G, Zhou H, Dai Z, Lu D, Chen T. Use of period analysis to timely assess 5-year relative survival for breast cancer patients from Taizhou, Eastern China. Front Oncol 2022;12:998641. [PMID: 36578940 DOI: 10.3389/fonc.2022.998641] [Reference Citation Analysis]
47 Zhang L, Liu X, Tong F, Zou R, Peng W, Yang H, Liu F, Yang D, Huang X, Yi L, Wen M, Jiang L. Cognitive behavioral therapy for anxiety and depression in cancer survivors: a meta-analysis. Sci Rep 2022;12:21466. [PMID: 36509786 DOI: 10.1038/s41598-022-25068-7] [Reference Citation Analysis]
48 Zhang LL, Zhu WJ, Zhang XX, Feng D, Wang XC, Ding Y, Wang DX, Li YY. Ferroptosis patterns and tumor microenvironment infiltration characterization in esophageal squamous cell cancer. Front Genet 2022;13:1047382. [PMID: 36568375 DOI: 10.3389/fgene.2022.1047382] [Reference Citation Analysis]
49 Ma Y, Chen J, Yao X, Li Z, Li W, Wang H, Zhu J. Patterns and prognostic predictive value of perineural invasion in esophageal squamous cell carcinoma. BMC Cancer 2022;22:1287. [PMID: 36482313 DOI: 10.1186/s12885-022-10386-w] [Reference Citation Analysis]
50 Cheng C, Cui H, Liu H, Wu Y, Ding N, Weng Y, Zhang W, Cui Y. Role of Epidermal Growth Factor Receptor-Specific CAR-T Cells in the Suppression of Esophageal Squamous Cell Carcinoma. Cancers (Basel) 2022;14. [PMID: 36551506 DOI: 10.3390/cancers14246021] [Reference Citation Analysis]
51 Chen X, Giles J, Yao Y, Yip W, Meng Q, Berkman L, Chen H, Chen X, Feng J, Feng Z, Glinskaya E, Gong J, Hu P, Kan H, Lei X, Liu X, Steptoe A, Wang G, Wang H, Wang H, Wang X, Wang Y, Yang L, Zhang L, Zhang Q, Wu J, Wu Z, Strauss J, Smith J, Zhao Y. The path to healthy ageing in China: a Peking University-Lancet Commission. Lancet 2022;400:1967-2006. [PMID: 36423650 DOI: 10.1016/S0140-6736(22)01546-X] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
52 Shen Y, Shao Y, Ruan X, Zhu L, Zang Z, Wei T, Nakyeyune R, Wei W, Liu F. Genetic variant in miR-17-92 cluster binding sites is associated with esophageal squamous cell carcinoma risk in Chinese population. BMC Cancer 2022;22:1253. [PMID: 36461008 DOI: 10.1186/s12885-022-10360-6] [Reference Citation Analysis]
53 Li J, Gu L, Xu J, Su X, Guo Y. Development and validation of Adaptability to Return-to-Work Scale (ARTWS) for cancer patients.. [DOI: 10.21203/rs.3.rs-2323264/v1] [Reference Citation Analysis]
54 Xu L, Kang W, Qiao L, Ren J, Liu G, Wang S, Xi Y, Zhan S. Suicides among cancer patients in Inner Mongolia Autonomous Region: A population-based study. Asian J Psychiatr 2022;78:103291. [PMID: 36228425 DOI: 10.1016/j.ajp.2022.103291] [Reference Citation Analysis]
55 Cao M, Liu C, Wang H, Lei L, Cao M, Wang Y, Li H, Yan X, Li Y, Wang X, Peng J, Qu C, Feletto E, Shi J, Chen W. The population-level economic burden of liver cancer in China, 2019–2030: prevalence-based estimations from a societal perspective. Cost Eff Resour Alloc 2022;20. [DOI: 10.1186/s12962-022-00370-3] [Reference Citation Analysis]
56 Li H, Wu H, Cao M, Yu Y, Zhou J, Zhang S, Tong F, Gong J, Wang H, Yang F, He S, Yan X, Zhang S, Luo P, Ma H, Liang L, Xia C, Chen W. Long-term Incidence Rates of Esophageal Squamous Cell Carcinoma in Chinese Patients With Low-grade Intraepithelial Neoplasia and Association of Surveillance Endoscopy With Incidence. JAMA Netw Open 2022;5:e2247415. [PMID: 36534402 DOI: 10.1001/jamanetworkopen.2022.47415] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
57 Li F, Liu M, Guo C, Xu R, Li F, Liu Z, Pan Y, Liu F, Liu Y, Cai H, He Z, Ke Y. Cost-effectiveness of precision screening for esophageal cancer based on individualized risk stratification in China: Real-world evidence from the ESECC trial. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1002693] [Reference Citation Analysis]
58 Li Q, Zhang X, Fan B, Yang Y, Cui X, Zhang J, Jiang K, Zhang C, Zhang B. Anlotinib combined with TAS-102 as the third-line treatment for a patient with metastatic colon cancer: A case report. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.978005] [Reference Citation Analysis]
59 Shen Y, Huang Y, Wang W, Zhang J, Chen X, Zhang L, Huang X, Ge Y. Prevalence and genotype distribution of HPV infection among women in Xiamen, China.. [DOI: 10.21203/rs.3.rs-2308084/v1] [Reference Citation Analysis]
60 Wei SH, Zhang JM, Shi B, Gao F, Zhang ZX, Qian LT. The value of CT radiomics features to predict visceral pleural invasion in ≤3 cm peripheral type early non-small cell lung cancer. J Xray Sci Technol 2022;30:1115-26. [PMID: 35938237 DOI: 10.3233/XST-221220] [Reference Citation Analysis]
61 Li X, Gao C, Wei Y, Wen Z, Li X, Liu F, Gong T, Yan S, Qin X, Gao S, Zhao Y, Wu Q. Pre-Diagnosis Sleep Status and Survival after a Diagnosis of Ovarian Cancer: A Prospective Cohort Study. J Clin Med 2022;11. [PMID: 36498489 DOI: 10.3390/jcm11236914] [Reference Citation Analysis]
62 Lyu B, Jin X. Status of Endoscopic Screening Strategies for Upper Gastrointestinal Tract Cancer. Cancer Screening and Prevention 2022;000:000-000. [DOI: 10.14218/csp.2022.00007] [Reference Citation Analysis]
63 Zheng X, Qian K. Neutrophil-to-lymphocyte ratio predicts therapy outcomes of transarterial chemoembolization combined with tyrosine kinase inhibitors plus programmed cell death ligand 1 antibody for unresectable hepatocellular carcinoma. Anticancer Drugs 2022. [PMID: 36730299 DOI: 10.1097/CAD.0000000000001458] [Reference Citation Analysis]
64 Feng R, Su Q, Huang X, Basnet T, Xu X, Ye W. Cancer situation in China: what does the China cancer map indicate from the first national death survey to the latest cancer registration? Cancer Commun (Lond) 2023;43:75-86. [PMID: 36397729 DOI: 10.1002/cac2.12393] [Reference Citation Analysis]
65 Qi X, Guo J, Chen G, Fang C, Hu L, Li J, Zhang C. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma. J Immunol Res 2022;2022:3393027. [PMID: 36438201 DOI: 10.1155/2022/3393027] [Reference Citation Analysis]
66 Ge M, Gao M, Cheng R, Chen X, Guan H, Lin Y, Liu S, Wang Y, Zheng C, Zheng X. CACA guidelines for holistic integrative management of thyroid cancer. Holist Integ Oncol 2022;1:17. [DOI: 10.1007/s44178-022-00015-8] [Reference Citation Analysis]
67 Fang Y, Xu Y, Liao W, Ji T, Yu L, Li L, Pan M, Yang D. Multiomics analyses and machine learning of nuclear receptor coactivator 6 reveal its essential role in hepatocellular carcinoma. Cancer Sci 2023;114:75-90. [PMID: 36086920 DOI: 10.1111/cas.15577] [Reference Citation Analysis]
68 Tang H, Zhang Y, Cao B, Liang Y, Na R, Yang Z, Lang H, Shang L. Knowledge, Attitudes and Behaviors toward Healthy Eating among Chinese Cancer Patients Treated with Chemotherapy: A Systematic Review. Asia-Pacific Journal of Oncology Nursing 2022. [DOI: 10.1016/j.apjon.2022.100163] [Reference Citation Analysis]
69 Li L, Feng R, Li Y, Yu X, Liu Y, Zhao Y, Liu Z. Caspase-8 mutants activate Nrf2 via phosphorylating SQSTM1 to protect against oxidative stress in esophageal squamous cell carcinoma. Free Radic Biol Med 2022;192:51-62. [PMID: 36165926 DOI: 10.1016/j.freeradbiomed.2022.09.013] [Reference Citation Analysis]
70 Tan L, Fang P, Cui J, Yu H, Yu L. Effects of progressive muscle relaxation on health-related outcomes in cancer patients: A systematic review and meta-analysis of randomized controlled trials. Complementary Therapies in Clinical Practice 2022;49:101676. [DOI: 10.1016/j.ctcp.2022.101676] [Reference Citation Analysis]
71 Xia C, Chen W. The NCC mathematical modeling framework for decision-making of six major cancers. Journal of the National Cancer Center 2022. [DOI: 10.1016/j.jncc.2022.11.002] [Reference Citation Analysis]
72 Qiu A, Xu H, Mao L, Xu B, Fu X, Cheng J, Zhao R, Cheng Z, Liu X, Xu J, Zhou Y, Dong Y, Tian T, Tian G, Chu M. A Novel apaQTL-SNP for the Modification of Non-Small-Cell Lung Cancer Susceptibility across Histological Subtypes. Cancers (Basel) 2022;14. [PMID: 36358727 DOI: 10.3390/cancers14215309] [Reference Citation Analysis]
73 Cui H, Zhou Y, Wang F, Cheng C, Zhang W, Sun R, Zhang L, Bi Y, Guo M, Zhou Y, Wang X, Ren J, Bai R, Ding N, Cheng C, Wang L, Zhuang X, Gao M, Weng Y, Wu Y, Liu H, Li S, Wang S, Cheng X, Cui Y, Liu Z, Zhan Q. Characterization of somatic structural variations in 528 Chinese individuals with Esophageal squamous cell carcinoma. Nat Commun 2022;13:6296. [PMID: 36272974 DOI: 10.1038/s41467-022-33994-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Han Y, Zhu X, Hu Y, Yu C, Guo Y, Hang D, Pang Y, Pei P, Ma H, Sun D, Yang L, Chen Y, Du H, Yu M, Chen J, Chen Z, Huo D, Jin G, Lv J, Hu Z, Shen H, Li L. Electronic Health Record–Based Absolute Risk Prediction Model for Esophageal Cancer in the Chinese Population: Model Development and External Validation (Preprint).. [DOI: 10.2196/preprints.43725] [Reference Citation Analysis]
75 Xu X, Jing J. Inflammation-related parameter serve as prognostic biomarker in esophageal squamous cell carcinoma. Front Oncol 2022;12:900305. [DOI: 10.3389/fonc.2022.900305] [Reference Citation Analysis]
76 Lin Y, Qin S, Yang H, Shi F, Yang A, Han X, Liu B, Li Z, Ji Q, Tang L, Deng Z, Ding Y, Fu W, Xie X, Li L, He X, Lv Z, Ma Q, Shen Z, Guo Z, Chen Z, Cui Y, Tan J, Gao Z, Jing S, Lu K, Luo X, Zhang Y, Fang Y, Li Z, Cheng Y, Lei S, Luan X, Chen G, Wang G, Wu L, Liu L. Donafenib in Locally Advanced/Metastatic Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trial (DIRECTION).. [DOI: 10.21203/rs.3.rs-2166215/v1] [Reference Citation Analysis]
77 Gao J, Li J, Chen W, Song J, Zhou M, Zhang S, Li H. A randomized controlled trial of a coping-focused family resilience intervention program for breast cancer patients: Study protocol. Front Psychol 2022;13:968154. [DOI: 10.3389/fpsyg.2022.968154] [Reference Citation Analysis]
78 He X, Qian W, Zhao S, Qi W. Knowledge of early gastric cancer screening among adults ≥45 years in China: Who, when, and how.. [DOI: 10.21203/rs.3.rs-2107113/v1] [Reference Citation Analysis]
79 Xiao Y, Qiu M, Tan C, Huang W, Hu S, Jiang X, Guo M, Wang C, Liang J, Wu Y, Li M, Li Q, Qin C. Systematic analysis of circRNA biomarkers for diagnosis, prognosis and therapy in colorectal cancer. Front Genet 2022;13:938672. [DOI: 10.3389/fgene.2022.938672] [Reference Citation Analysis]
80 Lin Y, Guo Z, Huang S, Ma J, Xiang Z, Huang Y, Zhou Y, Chen W. Time Trend of Upper Gastrointestinal Cancer Incidence in China from 1990 to 2019 and Analysis Using an Age-Period-Cohort Model. Curr Oncol 2022;29:7470-81. [PMID: 36290865 DOI: 10.3390/curroncol29100588] [Reference Citation Analysis]
81 Tang X, Liang Y, Sun G, He Q, Hou Z, Jiang X, Gao P, Qu H. Upregulation of CRABP2 by TET1-mediated DNA hydroxymethylation attenuates mitochondrial apoptosis and promotes oxaliplatin resistance in gastric cancer. Cell Death Dis 2022;13:848. [PMID: 36195596 DOI: 10.1038/s41419-022-05299-2] [Reference Citation Analysis]
82 Yuan J, Sun Y, Xu F, Li M, Fan M, Zhang C, Wang K, Li H, Bu X, Yan X, Wang J, Ma J, Zhang G, Chen M, Ren H. Cost-effectiveness of lung cancer screening combined with nurse-led smoking cessation intervention: A population-based microsimulation study. International Journal of Nursing Studies 2022;134:104319. [DOI: 10.1016/j.ijnurstu.2022.104319] [Reference Citation Analysis]
83 Xu M, Xie LT, Xiao YY, Liang P, Zhao QY, Wang ZM, Chai WL, Wei YT, Xu LF, Hu XK, Kuang M, Niu LZ, Yao CG, Kong HY, Tian G, Xie XY, Cui XW, Xu D, Zhao J, Jiang TA; Interventional Diagnosis and Treatment Group of the Ultrasonic Medicine Branch of Chinese Medical Association, Nanoknife Tumor Ablation Society of the Interventional Minimally Invasive Therapy Special Committee of China Medicine Education Association. Chinese clinical practice guidelines for ultrasound-guided irreversible electroporation of liver cancer (version 2022). Hepatobiliary Pancreat Dis Int 2022;21:462-71. [PMID: 36058782 DOI: 10.1016/j.hbpd.2022.08.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Zhao C, Yang ZY, Zhang J, Li O, Liu SL, Cai C, Shu YJ, Pan LJ, Gong W, Dong P. Inhibition of XPO1 with KPT-330 induces autophagy-dependent apoptosis in gallbladder cancer by activating the p53/mTOR pathway. J Transl Med 2022;20:434. [PMID: 36180918 DOI: 10.1186/s12967-022-03635-w] [Reference Citation Analysis]
85 Li R, Zhang Q, Feng D, Jin F, Han S, Yu X. Case report: Lymph node metastases of breast cancer and thyroid cancer encountered in axilla. Front Oncol 2022;12:983996. [DOI: 10.3389/fonc.2022.983996] [Reference Citation Analysis]
86 Zeng X, Zhou Z, Luo X, Liu Q. Lung cancer screening with low-dose computed tomography: National expenditures and cost-effectiveness. Front Public Health 2022;10:977550. [PMID: 36249202 DOI: 10.3389/fpubh.2022.977550] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 Zhu J, Sun K, Wang J, He Y, Li D, Liu S, Huang Y, Zhang M, Song B, Liao X, Liang H, Zhang Q, Shi M, Guo L, Zhou Y, Lin Y, Lu Y, Tuo J, Xia Y, Sun H, Xiao H, Ji Y, Yan C, Qiao J, Zeng H, Zheng R, Zhang S, Liu S, Chang S, Wei W. Clinicopathological and surgical comparisons of differentiated thyroid cancer between China and the USA: A multicentered hospital-based study. Front Public Health 2022;10:974359. [PMID: 36249201 DOI: 10.3389/fpubh.2022.974359] [Reference Citation Analysis]
88 Yan S, Shang Q, Fan Z, Yang Y, Liu Y, Gao H, Chen K, Liang F, Li X, Zhang Q, Yan H, Wang F. Expression of PD-L1 and YWHAZ in Patients with Diffuse Large B Cell Lymphoma: A Possible Association with the Prognosis of Lymphoma. Journal of Immunology Research 2022;2022:1-18. [DOI: 10.1155/2022/5633096] [Reference Citation Analysis]
89 Wang F, Li Y, Li Z, Zou Z, Lu Y, Xu C, Zhao Z, Wang H, Wang Y, Guo S, Jin L, Wang J, Li Q, Jiang G, Xia F, Shen B, Wu J. Prognostic value of GPC5 polymorphism rs2352028 and clinical characteristics in Chinese lung cancer patients. Future Oncol 2022. [PMID: 36165234 DOI: 10.2217/fon-2022-0319] [Reference Citation Analysis]
90 Liu Z, Zhao L, Sun W, Zhang Z, Wang D, Ding D, Xie D, Bi L, Yu D. p-Phenylenediamine induces epithelial-mesenchymal transition in SV-40 immortalized human urothelial cells via the ERK5/AP-1 signaling. Toxicol Lett 2022;371:1-8. [PMID: 36174792 DOI: 10.1016/j.toxlet.2022.09.010] [Reference Citation Analysis]
91 Li Z, Gao H, Zhang X, Liu Q, Chen G. Mutational and transcriptional alterations and clinicopathological factors predict the prognosis of stage I hepatocellular carcinoma: Prediction of stage I HCC prognosis. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-022-02496-3] [Reference Citation Analysis]
92 Liu R, Li Q, Li Y, Wei W, Ma S, Wang J, Zhang N. Public Preference Heterogeneity and Predicted Uptake for Upper Gastrointestinal Cancer Screening: A Latent Class Analysis (Preprint).. [DOI: 10.2196/preprints.42898] [Reference Citation Analysis]
93 Liu J, Dong L, Zhu Y, Dong B, Sha J, Zhu HH, Pan J, Xue W. Prostate cancer treatment - China's perspective. Cancer Lett 2022;:215927. [PMID: 36162714 DOI: 10.1016/j.canlet.2022.215927] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
94 Jiang D, Niu Z, Tan X, He H, Ren L, Shen J, Zhu X, Zhao P, Liu M, Chen H, Wang R, Li Q, Cao G. The mortalities of female-specific cancers in China and other countries with distinct socioeconomic statuses: A longitudinal study. J Adv Res 2022:S2090-1232(22)00204-1. [PMID: 36130684 DOI: 10.1016/j.jare.2022.09.002] [Reference Citation Analysis]
95 Zhang Y, Li Z, Pang Y, He Y, He S, Su Z, Zhou Y, Wang Y, Wang B, Song L, Li J, Han X, Zhou C, Li X, Tang L, Sun Y. Changes in Patient-Reported Health Status in Advanced Cancer Patients from a Symptom Management Clinic: A Longitudinal Study Conducted in China. Journal of Oncology 2022;2022:1-10. [DOI: 10.1155/2022/7531545] [Reference Citation Analysis]
96 Tan J, Chen F, Ouyang B, Li X, Zhang W, Gao X. CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma. Front Oncol 2022;12:865756. [DOI: 10.3389/fonc.2022.865756] [Reference Citation Analysis]
97 Qu R, Tu D, Cai Y, Ping W, Fu X. Clinical features and surgical outcomes of young patients with lung adenocarcinoma manifesting as ground glass opacity. Front Oncol 2022;12:979522. [DOI: 10.3389/fonc.2022.979522] [Reference Citation Analysis]
98 Chen F, Chi J, Zhao B, Mei F, Gao Q, Zhao L, Ma B. Impact of preoperative sarcopenia on postoperative complications and survival outcomes of patients with esophageal cancer: a meta-analysis of cohort studies. Dis Esophagus 2022;35:doab100. [PMID: 35077542 DOI: 10.1093/dote/doab100] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Li N, Zhu X, Nian W, Li Y, Sun Y, Yuan G, Zhang Z, Yang W, Xu J, Lizaso A, Li B, Zhang Z, Wu L, Zhang Y. Blood-based DNA methylation profiling for the detection of ovarian cancer. Gynecol Oncol 2022:S0090-8258(22)00480-2. [PMID: 36096974 DOI: 10.1016/j.ygyno.2022.07.008] [Reference Citation Analysis]
100 Liu Jr Y, Zhang X, Xu H, Shi J, Zhao Y, Du L, Liu Y, Wang W, Cao H, Ma L, Huang J, Cao J, Li L, Fan Y, Gu X, Feng C, Zhu Q, Wang X, Du J, Zhang J, Zhang S, Qiao Y. Real-world evidence on the uptake, barriers and associated factors with targeted therapy among metastatic colorectal cancer patients in China: A multi-center, cross-sectional survey (Preprint).. [DOI: 10.2196/preprints.42531] [Reference Citation Analysis]
101 Zheng J, Chen X, Huang B, Li J. A novel immune-related radioresistant lncRNAs signature based model for risk stratification and prognosis prediction in esophageal squamous cell carcinoma. Front Genet 2022;13:921902. [DOI: 10.3389/fgene.2022.921902] [Reference Citation Analysis]
102 Cui M, Yi X, Cao Z, Zhu D, Wu J, Raghavamenon AC. Targeting Strategies for Aberrant Lipid Metabolism Reprogramming and the Immune Microenvironment in Esophageal Cancer: A Review. Journal of Oncology 2022;2022:1-27. [DOI: 10.1155/2022/4257359] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
103 Zhang M, Cheng Y, Chen B, Li R, Jiang X, Wang L, Chen T, Liao Q, Chen J. Using period analysis to timely assess and predict 5-year relative survival for colorectal cancer patients in Taizhou, eastern China. Cancer Med 2023;12:3696-704. [PMID: 36065512 DOI: 10.1002/cam4.5220] [Reference Citation Analysis]
104 Wang C, Liu J, Lei H, Li Y, Wu J, Guo B, Hu R, Liu T, Wu J, Ding Y, Hu C, Liang S, Xiao C, Liang X, Huang D, Yang T, Zhang W, Yang Z, Li J, Nan Y, Li Q, Xiang Y, Li Z, Wu Y, Liu Y. Clinical characteristics and outcomes of newly diagnosed patients with HIV ‐associated aggressive B‐cell NHL in China. J Cellular Molecular Medi. [DOI: 10.1111/jcmm.17534] [Reference Citation Analysis]
105 Huang Q, Liu Y, Qiu M, Lin Q, Wei X, Zhou Z, Liang X, Li R, Chen W, Zhou X, Yu H. Potentially functional variants of MAP3K14 in the NF-κB signaling pathway genes predict survival of HBV-related hepatocellular carcinoma patients. Front Oncol 2022;12:990160. [DOI: 10.3389/fonc.2022.990160] [Reference Citation Analysis]
106 Li WQ, Qin XX, Li ZX, Wang LH, Liu ZC, Fan XH, Zhang LH, Li Y, Wu XZ, Ma JL, Zhang Y, Zhang LF, Li M, Zhou T, Zhang JY, Wang JX, Liu WD, You WC, Pan KF. Beneficial effects of endoscopic screening on gastric cancer and optimal screening interval: a population-based study. Endoscopy 2022;54:848-58. [PMID: 34963146 DOI: 10.1055/a-1728-5673] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
107 Guo Y. Therapy of head and neck cancer in China: Introduction to the special issue. Head Neck 2022;44:2007-8. [PMID: 35915866 DOI: 10.1002/hed.27129] [Reference Citation Analysis]
108 Li Z, Hao E, Cao R, Lin S, Zou L, Huang T, Du Z, Hou X, Deng J. Analysis on internal mechanism of zedoary turmeric in treatment of liver cancer based on pharmacodynamic substances and pharmacodynamic groups. Chinese Herbal Medicines 2022. [DOI: 10.1016/j.chmed.2022.06.007] [Reference Citation Analysis]
109 Kang W, Zeng H, Xiong J, Li Y, Jin P, Shao X, Hu H, Wang B, Xie Y, Tian Y. Survival of patients with gastric cancer surgically treated at the National Cancer Center of China from 2011 to 2018 according to stage at diagnosis. Journal of the National Cancer Center 2022;2:132-138. [DOI: 10.1016/j.jncc.2022.07.002] [Reference Citation Analysis]
110 Zheng R, Zhang S, Wang S, Chen R, Sun K, Zeng H, Li L, Wei W, He J. Lung cancer incidence and mortality in China: Updated statistics and an overview of temporal trends from 2000 to 2016. Journal of the National Cancer Center 2022;2:139-147. [DOI: 10.1016/j.jncc.2022.07.004] [Reference Citation Analysis]
111 Yang J, Guo W, Huang R, Xu Z, Zhou C, Lu M. Ultrasound-guided microwave ablation in the treatment of early-stage tongue cancer. Front Oncol 2022;12:950228. [DOI: 10.3389/fonc.2022.950228] [Reference Citation Analysis]
112 Maomao C, He L, Dianqin S, Siyi H, Xinxin Y, Fan Y, Shaoli Z, Changfa X, Lin L, Ji P, Wanqing C. Current cancer burden in China: epidemiology, etiology, and prevention. Cancer Biol Med 2022;19:j. [PMID: 36069534 DOI: 10.20892/j.issn.2095-3941.2022.0231] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
113 Yang Y, Zhao Y, Sun G, Zuo S, Chai J, Xu T, Liu J, Li L, Song J, Qian S, Kang Y, Sui F, Li M, Jia Q. FBXO39 predicts poor prognosis and correlates with tumor progression in cervical squamous cell carcinoma. Pathol Res Pract 2022;238:154090. [PMID: 36049441 DOI: 10.1016/j.prp.2022.154090] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
114 Hu GN, Wang Y, Tang CH, Jin LL, Huang BF, Wang Q, Shao JK, Wang CQ, Su CM. The impact of Angiopoietin-2 genetic polymorphisms on susceptibility for malignant breast neoplasms. Sci Rep 2022;12:14522. [PMID: 36008514 DOI: 10.1038/s41598-022-18712-9] [Reference Citation Analysis]
115 Zhang Q, Ren D, Chang X, Sun C, Liu R, Wang J, Zhang N. Willingness to pay for packaging cancer screening of Chinese rural residents. Cancer Med 2023;12:3532-42. [PMID: 36000818 DOI: 10.1002/cam4.5162] [Reference Citation Analysis]
116 Cao L, Lu S, Guo C, Chen W, Gao Y, Ye D, Guo Z, Ma W. A novel electrochemical immunosensor based on PdAgPt/MoS2 for the ultrasensitive detection of CA 242. Front Bioeng Biotechnol 2022;10:986355. [DOI: 10.3389/fbioe.2022.986355] [Reference Citation Analysis]
117 Wang T, Zhou Z, Wang X, You L, Li W, Zheng C, Zhang J, Wang L, Kong X, Gao Y, Sun X. Comprehensive analysis of nine m7G-related lncRNAs as prognosis factors in tumor immune microenvironment of hepatocellular carcinoma and experimental validation. Front Genet 2022;13:929035. [DOI: 10.3389/fgene.2022.929035] [Reference Citation Analysis]
118 Qiu J, Tang Y, Liu L, Yu J, Chen Z, Chen H, Yuan R. FOXM1 is regulated by DEPDC1 to facilitate development and metastasis of oral squamous cell carcinoma. Front Oncol 2022;12:815998. [DOI: 10.3389/fonc.2022.815998] [Reference Citation Analysis]
119 Wang R, Xu P, Zhou J, Meng Y, Men K, Zhang J, Lu W, Xue J, Li X. Short‐term outcomes in patients with lung cancer‐associated acute ischemic stroke. Thoracic Cancer. [DOI: 10.1111/1759-7714.14611] [Reference Citation Analysis]
120 Wang J, Coyte PC, Shao D, Zhen X, Zhao N, Sun C, Sun X. The Relationship between the Unmet Needs of Chinese Family Caregivers and the Quality of Life of Childhood Cancer Patients Undergoing Inpatient Treatment: A Mediation Model through Caregiver Depression. Int J Environ Res Public Health 2022;19. [PMID: 36011824 DOI: 10.3390/ijerph191610193] [Reference Citation Analysis]
121 Zhang L, Jiang Y, Jiang P, Chen Z, Cui H, Zhang Y. Efficacy and safety of Nimotuzumab combined with chemoradiotherapy in the treatment of locally advanced cervical cancer.. [DOI: 10.21203/rs.3.rs-1915592/v1] [Reference Citation Analysis]
122 Niu N, Li Y, Yu H, Guo L, Guo Z, Lan S, Liu Q, Zhang Y, Gui J, Wu D. The oncogenic function and potential mechanism of basic transcription factor 3 in melanoma.. [DOI: 10.21203/rs.3.rs-1946197/v1] [Reference Citation Analysis]
123 Zhang Y, Zhao J, Jiang N, Liu Y, Wang T, Yu X, Wang J, Yu J. The association between comorbidities and stigma among breast cancer survivors. Sci Rep 2022;12:13682. [PMID: 35953505 DOI: 10.1038/s41598-022-15460-8] [Reference Citation Analysis]
124 Huang Z, Liu W, Marzo RR, Hu Z, Wong LP, Lin Y. High-risk population's knowledge of risk factors and warning symptoms and their intention toward gastric cancer screening in Southeastern China. Front Public Health 2022;10:974923. [PMID: 36033804 DOI: 10.3389/fpubh.2022.974923] [Reference Citation Analysis]
125 Dai L, Mugaanyi J, Cai X, Dong M, Lu C, Lu C. Comprehensive bioinformatic analysis of MMP1 in hepatocellular carcinoma and establishment of relevant prognostic model. Sci Rep 2022;12:13639. [PMID: 35948625 DOI: 10.1038/s41598-022-17954-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
126 Qin S, Wang X, Li S, Tan C, Zeng X, Wu M, Peng Y, Wang L, Wan X. Benefit-to-harm ratio and cost-effectiveness of government-recommended gastric cancer screening in China: A modeling study. Front Public Health 2022;10:955120. [PMID: 36033760 DOI: 10.3389/fpubh.2022.955120] [Reference Citation Analysis]
127 Li L, Chen F, Liu J, Zhu W, Lin L, Chen L, Shi Y, Lin A, Chen G. Molecular classification grade 3 endometrial endometrioid carcinoma using a next-generation sequencing–based gene panel. Front Oncol 2022;12:935694. [DOI: 10.3389/fonc.2022.935694] [Reference Citation Analysis]
128 Dhakal R, Noula M, Roupa Z, Yamasaki EN. A Scoping Review on the Status of Female Breast Cancer in Asia with a Special Focus on Nepal. BCTT 2022;Volume 14:229-246. [DOI: 10.2147/bctt.s366530] [Reference Citation Analysis]
129 Liu L, Wu J, Shi M, Wang F, Lu H, Liu J, Chen W, Yu G, Liu D, Yang J, Luo Q, Ni Y, Jin X, Jin X, Chen WL. New Metabolic Alterations and A Predictive Marker Pipecolic Acid in Sera for Esophageal Squamous Cell Carcinoma. Genomics Proteomics Bioinformatics 2022;20:670-87. [PMID: 35351627 DOI: 10.1016/j.gpb.2021.08.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
130 Fang Y, Li Z, Chen H, Zhang T, Yin X, Man J, Yang X, Lu M. Burden of lung cancer along with attributable risk factors in China from 1990 to 2019, and projections until 2030. J Cancer Res Clin Oncol 2022. [PMID: 35904601 DOI: 10.1007/s00432-022-04217-5] [Reference Citation Analysis]
131 Lu H, Li L, Cheng Y, Yang Z, Cao X, Zhang H, Qiao D, Wang L, Chen T. Timely Estimates of 5-Year Relative Survival for Patients With Cervical Cancer: A Period Analysis Using Cancer Registry Data From Taizhou, Eastern China. Front Public Health 2022;10:926058. [DOI: 10.3389/fpubh.2022.926058] [Reference Citation Analysis]
132 Li Y, Diao Y, Wang Z, Wang S, Peng J, Kong B. The splicing factor SF3B4 drives proliferation and invasion in cervical cancer by regulating SPAG5. Cell Death Discov 2022;8:326. [PMID: 35853859 DOI: 10.1038/s41420-022-01120-3] [Reference Citation Analysis]
133 Yuan Y, Lin L, Xie C, Lu Y, Liang J, Qi Y, Dong B, Chen Q, Fang Q, Tian L. Effectiveness comparisons of various psychosocial therapies for cancer-related fatigue: A Bayesian network meta-analysis. J Affect Disord 2022;309:471-81. [PMID: 35504400 DOI: 10.1016/j.jad.2022.04.152] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
134 Yang B, Zhang X, Zhou H, Zhang X, Yang W, Lu J, Guo Z, Dong Z, Wu Q, Tian F. Preliminary study on the role and mechanism of KIRREL3 in the development of esophageal squamous cell carcinoma. Pathol Res Pract 2022;237:154025. [PMID: 35863131 DOI: 10.1016/j.prp.2022.154025] [Reference Citation Analysis]
135 Li J, Chen S, Liao Y, Wang H, Zhou D, Zhang B. Arecoline Is Associated With Inhibition of Cuproptosis and Proliferation of Cancer-Associated Fibroblasts in Oral Squamous Cell Carcinoma: A Potential Mechanism for Tumor Metastasis. Front Oncol 2022;12:925743. [DOI: 10.3389/fonc.2022.925743] [Reference Citation Analysis]
136 Lin YS, Yang H, Li XY, Wu LQ, Xu JG, Yang AM, Gao ZR, Ding Y, Zhang YQ, Chen K, Mu ZZ, Jia JM, Niu N, Sun D, Zhang X, Zhang SQ, Geng QQ, Zhang YJ, Chen FN, He BX. Novel recombinant human thyroid-stimulating hormone in aiding postoperative assessment of patients with differentiated thyroid cancer-phase I/II study. Eur J Nucl Med Mol Imaging 2022. [PMID: 35781600 DOI: 10.1007/s00259-022-05865-y] [Reference Citation Analysis]
137 Wang Y, Zhang L, Han F, Li R, Cheng Y, Jiang X, Wang L, Chen J, Ji J, Zhang Y, Chen T. Using Period Analysis to Timely Assess and Predict 5-Year Relative Survival for Liver Cancer Patients From Taizhou, Eastern China. Front Oncol 2022;12:920094. [DOI: 10.3389/fonc.2022.920094] [Reference Citation Analysis]
138 Qin S, Wang X, Li S, Tan C, Zeng X, Luo X, Yi L, Peng L, Wu M, Peng Y, Wang L, Wan X. Clinical Benefit and Cost Effectiveness of Risk-Stratified Gastric Cancer Screening Strategies in China: A Modeling Study. Pharmacoeconomics 2022;40:725-37. [PMID: 35701687 DOI: 10.1007/s40273-022-01160-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
139 Cheng S, Che L, Yang Q, Sun R, Nie Y, Shi H, Ding Y, Wang L, Du Z, Liu Z. Folic acid ameliorates N-methyl-N′-nitro-N-nitrosoguanidine-induced esophageal inflammation via modulation of the NF-κB pathway. Toxicology and Applied Pharmacology 2022;447:116087. [DOI: 10.1016/j.taap.2022.116087] [Reference Citation Analysis]
140 Yang K, Li J, Zhao L, Sun Z, Bai C. Estimating the number of Chinese cancer patients eligible for and benefit from immune checkpoint inhibitors. Front Med 2022. [PMID: 35776405 DOI: 10.1007/s11684-021-0902-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
141 Jeon M, Youn N, Kim S. What are the late effects of older gastric cancer survivors?: A scoping review. Asia-Pacific Journal of Oncology Nursing 2022. [DOI: 10.1016/j.apjon.2022.100113] [Reference Citation Analysis]
142 Wang P, Yang X, Liu D, Yang Y, Zhang Y, Wang G. Construction of a competing endogenous RNA network to analyse glucose-6-phosphate dehydrogenase dysregulation in hepatocellular carcinoma. Biosci Rep 2022;42:BSR20220674. [PMID: 35712981 DOI: 10.1042/BSR20220674] [Reference Citation Analysis]
143 Yuan X, Zhuang M, Zhu X, Cheng D, Liu J, Sun D, Qiu X, Lu Y, Sartorius K. Emerging Perspectives of Bone Metastasis in Hepatocellular Carcinoma. Front Oncol 2022;12:943866. [DOI: 10.3389/fonc.2022.943866] [Reference Citation Analysis]
144 Bu X, Li S, Cheng ASK, Ng PHF, Xu X, Xia Y, Liu X. Breast Cancer Stigma Scale: A Reliable and Valid Stigma Measure for Patients With Breast Cancer. Front Psychol 2022;13:841280. [PMID: 35756211 DOI: 10.3389/fpsyg.2022.841280] [Reference Citation Analysis]
145 Bi JH, Yuan HY, Jiang Y, Zhang Y, Zheng WW, Zhang L, Li ZY, Li HL, Tan YT, Zhao WS, Xiang YB. Incidence, Mortality Features and Lifetime Risk Estimation of Digestive Tract Cancers in an Urban District of Shanghai, China. J Epidemiol Glob Health 2022. [PMID: 35751747 DOI: 10.1007/s44197-022-00047-3] [Reference Citation Analysis]
146 Pan S, Yu Y, Wang S, Tu B, Shen Y, Qiu Q, Liu X, Su N, Zuo Y, Luan J, Zhang JY, Shi M, Meng F, Wang FS. Correlation of HBV DNA and Hepatitis B Surface Antigen Levels With Tumor Response, Liver Function and Immunological Indicators in Liver Cancer Patients With HBV Infection Undergoing PD-1 Inhibition Combinational Therapy. Front Immunol 2022;13:892618. [PMID: 35711409 DOI: 10.3389/fimmu.2022.892618] [Reference Citation Analysis]
147 Wang X, Sun Z, Makale EC, Sun Z, Wang T, Hou Z, Yu X, Long W, Du G, Huang H. Gut Microbial Profile in Patients with Pancreatic Cancer. Jundishapur J Microbiol 2022;15. [DOI: 10.5812/jjm-122386] [Reference Citation Analysis]
148 Luo Y, Wang Z, Xiao S, Li R, Jiang X, Tu W. G Protein-Coupled Receptor Kinase 4 Is a Novel Prognostic Factor in Hepatocellular Carcinoma. Disease Markers 2022;2022:1-11. [DOI: 10.1155/2022/2628879] [Reference Citation Analysis]
149 Xu ZH, Wang WQ, Liu L, Lou WH. A special subtype: Revealing the potential intervention and great value of KRAS wildtype pancreatic cancer. Biochim Biophys Acta Rev Cancer 2022;1877:188751. [PMID: 35732240 DOI: 10.1016/j.bbcan.2022.188751] [Reference Citation Analysis]
150 Ying Z, Qi D, Chaoran W, Min H, Miao W, Qin L. PARP inhibitors rising as an epoch-making strategy in first-line maintenance therapy of ovarian cancer: A systematic review and meta-analysis. Cancer Invest 2022;:1-15. [PMID: 35686725 DOI: 10.1080/07357907.2022.2088780] [Reference Citation Analysis]
151 Liu W, Qi J, Liu J, Song Y, Wang L, Zhou M, Ma J, Zhu J. Mortality Rate of Lymphoma in China, 2013–2020. Front Oncol 2022;12:902643. [DOI: 10.3389/fonc.2022.902643] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
152 Chen Z, Jiang Z, Meng L, Wang Y, Lin M, Wei Z, Han W, Ying S, Xu A. SAMHD1, positively regulated by KLF4, suppresses the proliferation of gastric cancer cells through MAPK p38 signaling pathway. Cell Cycle 2022;:1-14. [PMID: 35670736 DOI: 10.1080/15384101.2022.2085356] [Reference Citation Analysis]
153 Ssenyonga N, Stiller C, Nakata K, Shalkow J, Redmond S, Bulliard J, Girardi F, Fowler C, Marcos-gragera R, Bonaventure A, Saint-jacques N, Minicozzi P, De P, Rodríguez-barranco M, Larønningen S, Di Carlo V, Mägi M, Valkov M, Seppä K, Wyn Huws D, Coleman MP, Allemani C, Bouzbid S, Hamdi-chérif M, Kara L, Meguenni K, Regagba D, Bayo S, Cheick Bougadari T, Manraj SS, Bendahhou K, Ladipo A, Ogunbiyi O, Somdyala N, Chaplin MA, Moreno F, Calabrano G, Espinola S, Carballo Quintero B, Fita R, Laspada W, Ibañez S, Lima C, Mafra Da Costa A, De Souza PC, Chaves J, Laporte C, Curado MP, de Oliveira JC, Veneziano C, Veneziano D, Almeida AB, Latorre M, Azevedo e Silva G, Rebelo M, Santos M, Galaz J, Aparicio Aravena M, Sanhueza Monsalve J, Herrmann D, Vargas S, Herrera V, Uribe C, Bravo LE, Garcia LS, Arias-ortiz N, Morantes D, Jurado D, Yépez Chamorro M, Delgado S, Ramirez M, Galán Alvarez Y, Torres P, Martínez-reyes F, Jaramillo L, Quinto R, Castillo J, Mendoza M, Cueva P, Yépez J, Bhakkan B, Deloumeaux J, Joachim C, Macni J, Carrillo R, Shalkow Klincovstein J, Rivera Gomez R, Perez P, Poquioma E, Tortolero-luna G, Zavala D, Alonso R, Barrios E, Eckstrand A, Nikiforuk C, Woods R, Noonan G, Turner D, Kumar E, Zhang B, Dowden J, Doyle G, Saint-jacques N, Walsh G, Anam A, De P, Mcclure C, Vriends K, Bertrand C, Ramanakumar A, Kozie S, Stuart-panko H, Freeman T, George J, Avila R, O'brien D, Holt A, Almon L, Ward K, Kwong S, Morris C, Rycroft R, Mueller L, Phillips C, Brown H, Cromartie B, Ruterbusch J, Schwartz A, Levin G, Wohler B, Bayakly R, Gomez S, Mckinley M, Cress R, Davis J, Hernandez B, Johnson C, Morawski B, Ruppert L, Bentler S, Charlton M, Huang B, Tucker T, Deapen D, Liu L, Hsieh M, Wu X, Schwenn M, Stern K, Gershman S, Knowlton R, Alverson G, Weaver T, Desai J, Rogers D, Jackson-thompson J, Lemons D, Zimmerman H, Hood M, Roberts-johnson J, Hammond W, Rees J, Pawlish K, Stroup A, Key C, Wiggins C, Kahn A, Schymura M, Radhakrishnan S, Rao C, Giljahn L, Slocumb R, Dabbs C, Espinoza R, Aird K, Beran T, Rubertone J, Slack S, Oh J, Janes T, Schwartz S, Chiodini S, Hurley D, Whiteside M, Rai S, Williams M, Herget K, Sweeney C, Johnson A, Keitheri Cheteri M, Migliore Santiago P, Blankenship S, Farley S, Borchers R, Malicki R, Espinoza J, Grandpre J, Edwards B, Mariotto A, Weir H, Wilson R, Wang N, Yang L, Chen J, He Y, Song G, Gu X, Mei D, Ge H, Wu T, Li Y, Zhao D, Jin F, Zhang J, Zhu F, Junhua Q, Yang YL, Jiang C, Biao W, Wang J, Li Q, Yi H, Zhou X, Dong J, Li W, Fu F, Chen J, Zhu J, Li Y, Lu Y, Fan M, Huang S, Guo G, Zhaolai H, Wei K, Chen W, Wei W, Zeng H, Demetriou A, Mang WK, Ngan KC, Kataki A, Krishnatreya M, Jayalekshmi PA, Sebastian P, George P, Mathew A, Nandakumar A, Malekzadeh R, Roshandel G, Keinan-boker L, Silverman B, Ito H, Koyanagi Y, Sato M, Tobori F, Nakata I, Teramoto N, Hattori M, Kaizaki Y, Moki F, Sugiyama H, Utada M, Nishimura M, Yoshida K, Kurosawa K, Nemoto Y, Narimatsu H, Sakaguchi M, Kanemura S, Naito M, Narisawa R, Miyashiro I, Nakata K, Mori D, Yoshitake M, Oki I, Fukushima N, Shibata A, Iwasa K, Ono C, Matsuda T, Nimri O, Jung K, Won Y, Alawadhi E, Elbasmi A, Ab Manan A, Adam F, Nansalmaa E, Tudev U, Ochir C, Al Khater AH, El Mistiri M, Lim GH, Teo YY, Chiang C, Lee W, Buasom R, Sangrajrang S, Suwanrungruang K, Vatanasapt P, Daoprasert K, Pongnikorn D, Leklob A, Sangkitipaiboon S, Geater S, Sriplung H, Ceylan O, Kög I, Dirican O, Köse T, Gurbuz T, Karašahin FE, Turhan D, Aktaş U, Halat Y, Eser S, Yakut C, Altinisik M, Cavusoglu Y, Türkköylü A, Üçüncü N, Hackl M, Zborovskaya A, Aleinikova O, Henau K, Van Eycken L, Atanasov T, Valerianova Z, Šekerija M, Dušek L, Zvolský M, Steinrud Mørch L, Storm H, Wessel Skovlund C, Innos K, Mägi M, Malila N, Seppä K, Jégu J, Velten M, Cornet E, Troussard X, Bouvier A, Guizard A, Bouvier V, Launoy G, Dabakuyo Yonli S, Poillot M, Maynadié M, Mounier M, Vaconnet L, Woronoff A, Daoulas M, Robaszkiewicz M, Clavel J, Poulalhon C, Desandes E, Lacour B, Baldi I, Pouchieu C, Amadeo B, Coureau G, Monnereau A, Audoin M, D'almeida T, Boyer S, Hammas K, Trétarre B, Colonna M, Delafosse P, Plouvier S, Cowppli-bony A, Molinié F, Bara S, Ganry O, Lapôtre-ledoux B, Daubisse-marliac L, Bossard N, Estève J, Uhry Z, Stabenow R, Wilsdorf-köhler H, Eberle A, Luttmann S, Löhden I, Nennecke A, Kieschke J, Sirri E, Justenhoven C, Zeissig S, Holleczek B, Eisemann N, Katalinic A, Asquez R, Kumar V, Petridou E, Ólafsdóttir E, Tryggvadóttir L, Murray D, Walsh P, Sundseth H, Mazzoleni G, Vittadello F, Coviello E, Cuccaro F, Galasso R, Sampietro G, Magoni M, Ardizzone A, D'argenzio A, Di Prima AA, Ippolito A, Lavecchia AM, Sutera Sardo A, Gola G, Ballotari P, Giacomazzi E, Ferretti S, Dal Maso L, Serraino D, Celesia MV, Filiberti RA, Pannozzo F, Melcarne A, Quarta F, Andreano A, Russo AG, Carrozzi G, Cirilli C, Cavalieri d'Oro L, Rognoni M, Fusco M, Vitale MF, Usala M, Cusimano R, Mazzucco W, Michiara M, Sgargi P, Boschetti L, Chiaranda G, Seghini P, Maule M, Merletti F, Spata E, Tumino R, Mancuso P, Vicentini M, Cassetti T, Sassatelli R, Falcini F, Giorgetti S, Caiazzo AL, Cavallo R, Piras D, Bella F, Madeddu A, Fanetti AC, Maspero S, Carone S, Mincuzzi A, Candela G, Scuderi T, Gentilini MA, Rizzello R, Rosso S, Zanetti R, Caldarella A, Intrieri T, Bianconi F, Stracci F, Contiero P, Tagliabue G, Rugge M, Zorzi M, Beggiato S, Brustolin A, De Angelis R, Gatta G, Maurina A, Oniščuka M, Mousavi M, Lipunova N, Vincerzevskienė I, Agius D, Calleja N, Siesling S, Visser O, Johannesen T, Larønningen S, Trojanowski M, Mierzwa T, Rachtan J, Kępska K, Kościańska B, Wójcik-tomaszewska J, Motnyk M, Gos A, Bielska-lasota M, Didkowska J, Wojciechowska U, Forjaz de Lacerda G, Rego R, Carrito B, Pais A, Bento MJ, Rodrigues J, Lourenço A, Mayer-da-silva A, Blaga L, Coza D, Valkov M, Gusenkova L, Lazarevich O, Prudnikova O, Vjushkov DM, Egorova A, Orlov A, Pikalova L, Zhuikova L, Adamcik J, Safaei Diba C, Zadnik V, Zagar T, De-la-cruz M, Lopez-de-munain A, Aleman A, Rojas D, Chillarón RJ, Navarro AIM, Marcos-gragera R, Puigdemont M, Rodríguez-barranco M, Sánchez Perez M, Franch Sureda P, Ramos Montserrat M, Chirlaque López MD, Sánchez Gil A, Ardanaz E, Guevara M, Cañete-nieto A, Peris-bonet R, Carulla M, Galceran J, Almela F, Sabater C, Khan S, Pettersson D, Dickman P, Staehelin K, Struchen B, Herrmann C, Mousavi SM, Egger Hayoz C, Bouchardy C, Schaffar R, Went P, Bulliard J, Maspoli-conconi M, Kuehni C, Redmond S, Bordoni A, Ortelli L, Chiolero A, Konzelmann I, Rohrmann S, Wanner M, Broggio J, Rashbass J, Stiller C, Fitzpatrick D, Gavin A, Morrison D, Thomson C, Greene G, Huws D, Allemani C, Coleman M, Di Carlo V, Girardi F, Matz M, Minicozzi P, Sanz N, Ssenyonga N, Stephens R, Chalker E, Smith M, Gugusheff J, You H, Qin Li S, Dugdale S, Moore J, Philpot S, Pfeiffer R, Thomas H, Silva Ragaini B, Venn A, Evans S, Te Marvelde L, Savietto V, Trevithick R, Currow D, Fowler C, Lewis C. Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000–14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries. The Lancet Child & Adolescent Health 2022;6:409-431. [DOI: 10.1016/s2352-4642(22)00095-5] [Reference Citation Analysis]
154 Gao X, Wang WX, Zhang XL. A novel pyroptosis risk model composed of NLRP6 effectively predicts the prognosis of hepatocellular carcinoma patients. Cancer Med 2023;12:808-23. [PMID: 35651286 DOI: 10.1002/cam4.4898] [Reference Citation Analysis]
155 Li YD, Li HZ, Chen SS, Jin CH, Chen M, Cheng M, Ma MJ, Zhang XP, Wang X, Zhou JB, Chen MT, Chen JN, Yu S, Wang TJ, Fang WP, Cao XW, Yu XJ, Du LB, Wang S. Correlation of the detection rate of upper GI cancer with artificial intelligence score: results from a multicenter trial (with video). Gastrointest Endosc 2022;95:1138-1146.e2. [PMID: 34973966 DOI: 10.1016/j.gie.2021.12.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
156 Xiang YC, Peng P, Liu XW, Jin X, Shen J, Zhang T, Zhang L, Wan F, Ren YL, Yu QQ, Zhao HZ, Si Y, Liu Y. Paris saponin VII, a Hippo pathway activator, induces autophagy and exhibits therapeutic potential against human breast cancer cells. Acta Pharmacol Sin 2022;43:1568-80. [PMID: 34522004 DOI: 10.1038/s41401-021-00755-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
157 Wu NX, Deng LJ, Xiong F, Xie JY, Li XJ, Zeng Q, Sun JC, Chen D, Yang P. Risk of thyroid cancer and benign nodules associated with exposure to parabens among Chinese adults in Wuhan, China. Environ Sci Pollut Res Int 2022. [PMID: 35581467 DOI: 10.1007/s11356-022-20741-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
158 Zhou S, Liu S, Tian G, Zhao L, Wang H, Li Y, Shen Y, Han L. KLK5 is associated with the radioresistance, aggression, and progression of cervical cancer. Gynecol Oncol 2022:S0090-8258(22)00309-2. [PMID: 35595569 DOI: 10.1016/j.ygyno.2022.05.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
159 Li L, Liu Y, Zhao Y, Feng R, Li Y, Yu X, Liu Z, Wang L. Deubiquitinase USP8 increases ID1 stability and promotes esophageal squamous cell carcinoma tumorigenesis. Cancer Letters 2022;542:215760. [DOI: 10.1016/j.canlet.2022.215760] [Reference Citation Analysis]
160 Zhang L, Nan F, Yang L, Dong Y, Tian Y. Differentially expressed EREG and SPP1 are independent prognostic markers in cervical squamous cell carcinoma. J of Obstet and Gynaecol. [DOI: 10.1111/jog.15265] [Reference Citation Analysis]
161 Guo Y, Zhang W, He R, Zheng C, Liu X, Ge M, Xu J. Investigating the Association Between rs2439302 Polymorphism and Thyroid Cancer: A Systematic Review and Meta-Analysis. Front Surg 2022;9. [DOI: 10.3389/fsurg.2022.877206] [Reference Citation Analysis]
162 Lu B, Wang L, Lu M, Zhang Y, Cai J, Luo C, Chen H, Dai M. Microsimulation Model for Prevention and Intervention of Coloretal Cancer in China (MIMIC-CRC): Development, Calibration, Validation, and Application. Front Oncol 2022;12:883401. [DOI: 10.3389/fonc.2022.883401] [Reference Citation Analysis]
163 Wang L, Liang M, Xiao Y, Chen J, Mei C, Lin Y, Zhang Y, Li D. NIR-II Navigation with an EGFR-Targeted Probe Improves Imaging Resolution and Sensitivity of Detecting Micrometastases in Esophageal Squamous Cell Carcinoma Xenograft Models. Mol Pharm 2022. [PMID: 35420035 DOI: 10.1021/acs.molpharmaceut.2c00115] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
164 Zheng Z, Zhu H, Cai H. Preoperative Prognostic Nutritional Index Predict Survival in Patients With Resectable Esophageal Squamous Cell Carcinoma. Front Nutr 2022;9:824839. [DOI: 10.3389/fnut.2022.824839] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
165 Shen K, Liu K, Wang Y, Ni P, Xiao J, Hao F, Zhou X, Xu Z, Yang L. Polymorphisms of an oncogenic gene, mesothelin, predict the risk and prognosis of gastric cancer in a Chinese Han population. Arch Toxicol 2022. [PMID: 35396937 DOI: 10.1007/s00204-022-03290-6] [Reference Citation Analysis]
166 Tao X, Gandomkar Z, Li T, Reed WM, Brennan PC. Varying performance levels for diagnosing mammographic images depending on reader nationality have AI and educational implications. Medical Imaging 2022: Image Perception, Observer Performance, and Technology Assessment 2022. [DOI: 10.1117/12.2611342] [Reference Citation Analysis]
167 Zeng H, Liu Y, Wang L, Yin P, Wang B, Fu R, Ran X, Zheng R, Zhang S, Liu J, You J, Sun K, Wang S, Li L, Chen R, Wei W, Zhou M, Wu J, He J. National Cancer Data Linkage Platform of China: Design, Methods, and Application. China CDC Wkly 2022;4:271-5. [PMID: 35433086 DOI: 10.46234/ccdcw2022.068] [Reference Citation Analysis]
168 Li N, Tan F, Chen W, Dai M, Wang F, Shen S, Tang W, Li J, Yu Y, Cao W, Xu Y, Qin C, Zhao L, Zhu M, Guo L, Wu Z, Yang Z, Zheng Y, Chen H, Liu Y, Wei D, Dong D, Cao J, Zhang S, Yan S, Wang N, Du L, Shen H, Wu N, He J; National Lung Cancer Screening programme group. One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort study. Lancet Respir Med 2022;10:378-91. [PMID: 35276087 DOI: 10.1016/S2213-2600(21)00560-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 10.0] [Reference Citation Analysis]
169 Zhu D, Xu Y, Feng F, Wang Z, Han D, Zhou X. Effect of kangai injection combined with platinum-based chemotherapy on the immune function of patients with advanced non-small-cell lung cancer: A meta-analysis. Phytomedicine 2022;100:154088. [PMID: 35397286 DOI: 10.1016/j.phymed.2022.154088] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
170 Fan Z, Qin Y, Zhou J, Chen R, Gu J, Li M, Zhou J, Li X, Lin D, Wang J, Deng D, Wei W. Feasibility of using P16 methylation as a cytologic marker for esophageal squamous cell carcinoma screening: A pilot study. Cancer Med 2022. [PMID: 35352503 DOI: 10.1002/cam4.4718] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
171 Wang X, Li Y, Yang W, Zhong WL. Rapid Rehabilitation Program Can Promote the Recovery of Gastrointestinal Function, Speed Up the Postoperative Rehabilitation Process, and Reduce the Incidence of Complications in Patients Undergoing Radical Gastrectomy. Journal of Oncology 2022;2022:1-6. [DOI: 10.1155/2022/1386382] [Reference Citation Analysis]
172 Niu P, Huang H, Zhao L, Wang T, Zhang X, Wang W, Zhang Y, Guo C, Zhao D, Chen Y. Clinicopathological characteristics, survival outcomes, and genetic alterations of younger patients with gastric cancer: Results from the China National Cancer Center and cBioPortal datasets. Cancer Medicine. [DOI: 10.1002/cam4.4669] [Reference Citation Analysis]
173 Wu Z, Tang H, Wang L, Jin X, Lei Z, Yang P, Zhou J. Postoperative survival analysis of hepatocellular carcinoma patients with liver cirrhosis based on propensity score matching. BMC Surg 2022;22:103. [PMID: 35313836 DOI: 10.1186/s12893-022-01556-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
174 Zhou L, Li H, Cai H, Liu W, Pan E, Yu D, He S. Upregulation of IGF2BP2 Promotes Oral Squamous Cell Carcinoma Progression That Is Related to Cell Proliferation, Metastasis and Tumor-Infiltrating Immune Cells. Front Oncol 2022;12:809589. [PMID: 35299748 DOI: 10.3389/fonc.2022.809589] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
175 Zhang H, Xu H, Zhang ZX, Zhang Q. Efficacy of virtual reality-based interventions for patients with breast cancer symptom and rehabilitation management: a systematic review and meta-analysis. BMJ Open 2022;12:e051808. [PMID: 35301201 DOI: 10.1136/bmjopen-2021-051808] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
176 Zheng XD, Li SC, Lu C, Zhang WM, Hou JB, Shi KF, Zhang P. Safety and efficacy of minimally invasive McKeown esophagectomy in 1023 consecutive esophageal cancer patients: a single-center experience. J Cardiothorac Surg 2022;17:36. [PMID: 35292067 DOI: 10.1186/s13019-022-01781-2] [Reference Citation Analysis]
177 Li Z, Wu W, Pan X, Li F, Zhu Q, He Z, Chen L. Serum tumor markers level and their predictive values for solid and micropapillary components in lung adenocarcinoma. Cancer Med 2022. [PMID: 35289087 DOI: 10.1002/cam4.4645] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
178 Mei LX, Mo JX, Chen Y, Dai L, Wang YY, Chen MW. Esophagectomy versus definitive chemoradiotherapy as initial treatment for clinical stage I esophageal cancer: a systematic review and meta-analysis. Dis Esophagus 2022;35:doab049. [PMID: 34318324 DOI: 10.1093/dote/doab049] [Reference Citation Analysis]
179 Yan Q, Lin HM, Zhu K, Cao Y, Xu XL, Zhou ZY, Xu LB, Liu C, Zhang R. Immune Checkpoint FGL1 Expression of Circulating Tumor Cells Is Associated With Poor Survival in Curatively Resected Hepatocellular Carcinoma. Front Oncol 2022;12:810269. [PMID: 35273912 DOI: 10.3389/fonc.2022.810269] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
180 Wu Y, Lin H, You X, Guo T, Sun T, Xu H, Fu X. Immune Checkpoint Blockade in Chinese Patients With Hepatocellular Carcinoma: Characteristics and Particularity. Front Oncol 2022;12:764923. [DOI: 10.3389/fonc.2022.764923] [Reference Citation Analysis]
181 Liu Y, Xu HF, Zhang X, Yu YQ, Zhao YQ, Zhang SK, Qiao YL. Disease knowledge, medical experience, health-related quality of life and health-care costs among patients with advanced colorectal cancer in China: protocol for a nationwide multicentre survey. BMJ Open 2022;12:e054403. [PMID: 35264348 DOI: 10.1136/bmjopen-2021-054403] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
182 Tan D, Zhang Y. Silencing of Nudix type 5 represses proliferation and invasion and enhances chemosensitivity of gastric carcinoma cells by affecting the AKT/GSK-3β/β-catenin pathway. Toxicol Appl Pharmacol 2022;:115968. [PMID: 35247377 DOI: 10.1016/j.taap.2022.115968] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
183 Tan F, Bi N, Zhang H, Li R, Wang Z, Duan J, Jiang F, Feng D, Zhang R, Bai J, Cao J, Mao N, Liang K, Yin S, Shen Y, Feng F, Zhao J, Gao Y, Mao Y, Xue Q, Gao S, He J. External Validation of the Eighth Edition of the TNM Classification for Lung Cancer in Small Cell Lung Cancer. Lung Cancer 2022. [DOI: 10.1016/j.lungcan.2022.03.011] [Reference Citation Analysis]
184 Holzinger A, Dehmer M, Emmert-streib F, Cucchiara R, Augenstein I, Ser JD, Samek W, Jurisica I, Díaz-rodríguez N. Information fusion as an integrative cross-cutting enabler to achieve robust, explainable, and trustworthy medical artificial intelligence. Information Fusion 2022;79:263-78. [DOI: 10.1016/j.inffus.2021.10.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 17.0] [Reference Citation Analysis]
185 Yan Z, Da Q, Li Z, Lin Q, Yi J, Su Y, Yu G, Ren Q, Liu X, Lin Z, Qu J, Yin W, Liu J. Inhibition of NEK7 Suppressed Hepatocellular Carcinoma Progression by Mediating Cancer Cell Pyroptosis. Front Oncol 2022;12:812655. [PMID: 35223495 DOI: 10.3389/fonc.2022.812655] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
186 Liu D, Xia A, Wu L, Li S, Zhang K, Chen D. IGF2BP2 promotes gastric cancer progression by regulating the IGF1R-RhoA-ROCK signaling pathway. Cellular Signalling 2022. [DOI: 10.1016/j.cellsig.2022.110313] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
187 Bu X, Ng PH, Xu W, Cheng Q, Chen PQ, Cheng AS, Liu X. The Effectiveness of Virtual Reality-Based Interventions in Rehabilitation Management of Breast Cancer Survivors: Systematic Review and Meta-analysis. JMIR Serious Games 2022;10:e31395. [PMID: 35225817 DOI: 10.2196/31395] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
188 Tang Y, Zhao W, Li J, Xie P, Wang S, Yan L, Xing X, Lu J, Tse L, Wang HH, Liu X. Dietary intake of monounsaturated and polyunsaturated fatty acids is related to the reduced risk of esophageal squamous cell carcinoma. Lipids Health Dis 2022;21. [DOI: 10.1186/s12944-022-01624-y] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
189 Yu B, Lv G, Sohail M, Li Z, Li Y, Yu M, Sun F, Xu H, Lau ATY. Utilizing Bioinformatics Technology to Explore the Potential Mechanism of Danggui Buxue Decoction against NSCLC. Disease Markers 2022;2022:1-20. [DOI: 10.1155/2022/5296830] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
190 Bu X, Ng PHF, Chen Q, Cheng ASK, Xu W, Tong Y, Tang Q, Liu X. Effectiveness of virtual reality-based interventions in rehabilitation management of breast cancer survivors: protocol of a systematic review and meta-analysis. BMJ Open 2022;12:e053745. [PMID: 35173002 DOI: 10.1136/bmjopen-2021-053745] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
191 Wang L, Lu B, He M, Wang Y, Wang Z, Du L. Prostate Cancer Incidence and Mortality: Global Status and Temporal Trends in 89 Countries From 2000 to 2019. Front Public Health 2022;10:811044. [DOI: 10.3389/fpubh.2022.811044] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
192 Wang S, Cai W, Li J, An W, Zheng H, Liao M. Bioinformatics Analysis and Experimental Study of Exonuclease 1 Gene in Lung Adenocarcinoma. Biochem Genet 2022. [PMID: 35169964 DOI: 10.1007/s10528-022-10190-y] [Reference Citation Analysis]
193 Tan X, Liu S, Yao L, Cui G, Liu J, Ding J, Cao S. Comprehensive Analysis of a Novel Lipid Metabolism-Related Gene Signature for Predicting the Prognosis and Immune Landscape in Uterine Corpus Endometrial Carcinoma. Journal of Oncology 2022;2022:1-22. [DOI: 10.1155/2022/8028825] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
194 Zhou J, Zheng R, Zhang S, Chen R, Wang S, Sun K, Li M, Lei S, Zhuang G, Wei W. Gastric and esophageal cancer in China 2000 to 2030: Recent trends and short-term predictions of the future burden. Cancer Med 2022. [PMID: 35148032 DOI: 10.1002/cam4.4586] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
195 Wu D, Huang H, Zhang M, Li Z, Wang S, Yu Y, Fang Y, Jiang N, Miao H, Ma P, Tang Y, Li N. The global landscape of neoadjuvant and adjuvant anti-PD-1/PD-L1 clinical trials. J Hematol Oncol 2022;15:16. [PMID: 35135567 DOI: 10.1186/s13045-022-01227-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
196 Peng P, Xiao Y, Zhao Z, Sun C, Wu D, Chen Y, Zhang L. Treatment beyond progression with chemo-immunotherapy in an advanced esophageal squamous cell carcinoma patient: a case report. Transl Cancer Res 2021;10:4973-8. [PMID: 35116347 DOI: 10.21037/tcr-21-1395] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
197 Bu X, Jin C, Fan R, Cheng ASK, Ng PHF, Xia Y, Liu X. Unmet needs of 1210 Chinese breast cancer survivors and associated factors: a multicentre cross-sectional study. BMC Cancer 2022;22:135. [PMID: 35109799 DOI: 10.1186/s12885-022-09224-w] [Reference Citation Analysis]
198 Fu Z, Zhang R, Wang KH, Cong MH, Li T, Weng M, Guo ZQ, Li ZN, Li ZP, Wang C, Xu HX, Song CH, Zhuang CL, Zhang Q, Li W, Shi HP; INSCOC Study Group. Development and validation of a Modified Patient-Generated Subjective Global Assessment as a nutritional assessment tool in cancer patients. J Cachexia Sarcopenia Muscle 2022;13:343-54. [PMID: 34862759 DOI: 10.1002/jcsm.12872] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
199 Xing C, Yin H, Yao ZY, Xing XL. Prognostic Signatures Based on Ferroptosis- and Immune-Related Genes for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma. Front Oncol 2021;11:774558. [PMID: 35087751 DOI: 10.3389/fonc.2021.774558] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
200 Liang D, Shi J, Li D, Wu S, Jin J, He Y. Participation and Yield of a Lung Cancer Screening Program in Hebei, China. Front Oncol 2021;11:795528. [PMID: 35083151 DOI: 10.3389/fonc.2021.795528] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
201 Li J, Jia Z, Zhang M, Liu G, Xing Z, Wang X, Huang X, Feng K, Wu J, Wang W, Wang J, Liu J, Wang X. Cost-Effectiveness Analysis of Imaging Modalities for Breast Cancer Surveillance Among BRCA1/2 Mutation Carriers: A Systematic Review. Front Oncol 2021;11:763161. [PMID: 35083138 DOI: 10.3389/fonc.2021.763161] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
202 Zhu C, Lian Z, Chen Y, Wang J. Physical Activity and Cancer Status Among Middle-Aged and Older Chinese: A Population-Based, Cross-Sectional Study. Front Physiol 2022;12:812290. [DOI: 10.3389/fphys.2021.812290] [Reference Citation Analysis]
203 Cai A, Hu Y, Zhou Z, Qi Q, Wu Y, Dong P, Chen L, Wang F. PIWI-Interacting RNAs (piRNAs): Promising Applications as Emerging Biomarkers for Digestive System Cancer. Front Mol Biosci 2022;9:848105. [DOI: 10.3389/fmolb.2022.848105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
204 Xu Y, Liao W, Luo Q, Yang D, Pan M. Histone Acetylation Regulator-Mediated Acetylation Patterns Define Tumor Malignant Pathways and Tumor Microenvironment in Hepatocellular Carcinoma. Front Immunol 2022;13:761046. [DOI: 10.3389/fimmu.2022.761046] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
205 Fang L, Lv J, Xuan Z, Li B, Li Z, He Z, Li F, Xu J, Wang S, Xia Y, Jiang T, Zhang L, Wang L, Zhang D, Xu H, Yang L, Xu Z, Wang W. Circular CPM promotes chemoresistance of gastric cancer via activating PRKAA2‐mediated autophagy. Clinical & Translational Med 2022;12. [DOI: 10.1002/ctm2.708] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
206 Zhou T, Feng Z, Yang F, Zhu W, Cao J, Hou X, Zhao Y, Chen D. High expression of HOXB7 is an unfavorable prognostic factor for solid malignancies: A meta-analysis. Medicine (Baltimore) 2022;101:e28564. [PMID: 35060516 DOI: 10.1097/MD.0000000000028564] [Reference Citation Analysis]
207 Feng Y, Liang Y, Yao B, Xu J, Zang J, Zhang Y, Zhang J, Xu G, Wei B, Yao X, Huang P, Shi R. A Rapid Cytological Screening as pre-Endoscopy Screening for Early Esophageal Squamous Cell Lesions: A Prospective Pilot Study from a Chinese Academic Center. Technol Cancer Res Treat 2022;21:15330338211066200. [PMID: 35040718 DOI: 10.1177/15330338211066200] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
208 Zhang SZ, Xie L, Shang ZJ. Burden of Oral Cancer on the 10 Most Populous Countries from 1990 to 2019: Estimates from the Global Burden of Disease Study 2019. Int J Environ Res Public Health 2022;19:875. [PMID: 35055693 DOI: 10.3390/ijerph19020875] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
209 Li M, Diao Y, Ye J, Sun J, Jiang Y. The Public Health Insurance Coverage of Novel Targeted Anticancer Medicines in China-In Favor of Whom? A Retrospective Analysis of the Insurance Claim Data. Front Pharmacol 2021;12:778940. [PMID: 34992534 DOI: 10.3389/fphar.2021.778940] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
210 Aseafan M, Devol E, AlAhwal M, Souissi R, Sindi R, AlEid H, Bazarbashi S. Population-based survival for cancer patients in Saudi Arabia for the years 2005-2009. Sci Rep 2022;12:235. [PMID: 34997176 DOI: 10.1038/s41598-021-04374-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
211 Guo L, Lyu Z, Meng Q, Zheng L, Chen Q, Liu Y, Xu H, Kang R, Zhang L, Cao X, Liu S, Sun X, Zhang J, Zhang S. Construction and Validation of a Lung Cancer Risk Prediction Model for Non-Smokers in China. Front Oncol 2022;11:766939. [DOI: 10.3389/fonc.2021.766939] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
212 Ma L, Office of Epidemiology, Chinese Center for Disease Control and Prevention, Beijing, China, Li X, Wang M, Zhang Y, Wu J, He Y, Fan X, Zhang B, Zhou X, National Center for Chronic and Non-Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China. The Incidence, Mortality, and DALYs Trends Associated with Esophageal Cancer — China, 1990–2019. China CDC Weekly 2022;4:956-961. [DOI: 10.46234/ccdcw2022.006] [Reference Citation Analysis]
213 Teng Y, Ding X, Li W, Sun W, Chen J. A Retrospective Study on Therapeutic Efficacy of Transarterial Chemoembolization Combined With Immune Checkpoint Inhibitors Plus Lenvatinib in Patients With Unresectable Hepatocellular Carcinoma. Technol Cancer Res Treat 2022;21:15330338221075174. [PMID: 35313780 DOI: 10.1177/15330338221075174] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
214 Yang H, Kang Y, Li Y, Liu F, Yan S, Gao S, Huo Y, Gong T, Wu Q. Relationship between different forms of dietary choline and ovarian cancer survival: findings from the ovarian cancer follow-up study, a prospective cohort study. Food Funct 2022. [DOI: 10.1039/d2fo02594a] [Reference Citation Analysis]
215 Wang G, Beeraka NM, Xiao W, Zhang Y, Xue N, Chen G, Liu J, Liu Y. Comparative Clinical Efficacy of 'Concurrent Chemoradiotherapy (CCRT) and Anlotinib' Than CCRT in Patients with Locally Advanced ESCC. Technol Cancer Res Treat 2022;21:15330338221080939. [PMID: 35235470 DOI: 10.1177/15330338221080939] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
216 周 海. Endoscopic Diagnosis and Treatment of Two Cases of Basal Layer Squamous Cell Carcinoma. ACM 2022;12:104-108. [DOI: 10.12677/acm.2022.121018] [Reference Citation Analysis]
217 Gu JH, Gong TT, Wu QJ, Liu FH, Wen ZY, Gao C, Wei YF, Yang Z. Association Between Pre-diagnostic Dietary Supplements Intake and Ovarian Cancer Survival: Findings From a Prospective Cohort Study in Chinese Women. Front Nutr 2021;8:758178. [PMID: 34970575 DOI: 10.3389/fnut.2021.758178] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
218 Fan X, Zhang B, He Y, Zhou X, Zhang Y, Ma L, Li X, Wu J; National Center for Chronic and Noncommunicable Disease Control and Prevention, CDC China, Beijing, China, Inner Mongolia Medical University, Huhehot, Inner Mongolia Autonomous Region, China, Baotou Medical College, Baotou, Inner Mongolia Autonomous Region, China, Office of Epidemiology, Chinese Center for Disease Control and Prevention, Beijing, China. . China CDC Weekly 2022;4:306-11. [DOI: 10.46234/ccdcw2022.036] [Reference Citation Analysis]
219 Tuo JY, Bi JH, Yuan HY, Jiang YF, Ji XW, Li HL, Xiang YB. Trends of stomach cancer survival: A systematic review of survival rates from population-based cancer registration. J Dig Dis 2022;23:22-32. [PMID: 34821032 DOI: 10.1111/1751-2980.13070] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
220 He Y, Zhou X, Fan X, Zhang B, Ma L, Wu J, Li X; Baotou Medical College, Baotou, Inner Mongolia Autonomous Region, China, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China, Inner Mongolia Medical University, Huhehot, Inner Mongolia Autonomous Region, China, Office of Epidemiology, Chinese Center for Disease Control and Prevention, Beijing, China. . China CDC Weekly 2022;4:527-31. [DOI: 10.46234/ccdcw2022.056] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
221 Xie S, Huang R, Liu Y, Cao S, Qian C. An increase in early cancer detection rates at a single cancer center: Experiences from Sun Yat-sen University Cancer Center. Vis Cancer Med 2022;3:1. [DOI: 10.1051/vcm/2022001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
222 Xu X, Yang X, Liu X, Bi Y, Kong P, Wang Y, Cheng X, Xi Y. The Role of DBR1 as a Candidate Prognosis Biomarker in Esophageal Squamous Cell Carcinoma. Technol Cancer Res Treat 2022;21:15330338221083105. [PMID: 35244467 DOI: 10.1177/15330338221083105] [Reference Citation Analysis]
223 Liu X, Liu X, Han X. FANCI may serve as a prognostic biomarker for cervical cancer: A systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e27690. [PMID: 34941027 DOI: 10.1097/MD.0000000000027690] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
224 Fang L, Yang Z, Zhang M, Meng M, Feng J, Chen C. Clinical characteristics and survival analysis of colorectal cancer in China: a retrospective cohort study with 13,328 patients from southern China. Gastroenterol Rep (Oxf) 2021;9:571-82. [PMID: 34925854 DOI: 10.1093/gastro/goab048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
225 Su D. The transcatheter arterial chemoembolization combined with targeted nanoparticle delivering sorafenib system for the treatment of microvascular invasion of hepatocellular carcinoma. Bioengineered 2021;12:11124-35. [PMID: 34923912 DOI: 10.1080/21655979.2021.2001239] [Reference Citation Analysis]
226 Qin X, Ye D, Gu C, Huang Y, Gu W, Dai B, Zhang H, Zhu Y, Yang H, Qu S. Prostate Cancer Screening Using Prostate-Specific Antigen Tests in a High-Risk Population in China: A Cost-Utility Analysis. Curr Ther Res Clin Exp 2021;95:100653. [PMID: 34917218 DOI: 10.1016/j.curtheres.2021.100653] [Reference Citation Analysis]
227 Cheng Y, Wang G, Zhao L, Dai S, Han J, Hu X, Zhou C, Wang F, Ma H, Li B, Meng Z. Periplocymarin Induced Colorectal Cancer Cells Apoptosis Via Impairing PI3K/AKT Pathway. Front Oncol 2021;11:753598. [PMID: 34900704 DOI: 10.3389/fonc.2021.753598] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
228 Zhao Z, Du L, Wang L, Wang Y, Yang Y, Dong H. Preferred Lung Cancer Screening Modalities in China: A Discrete Choice Experiment. Cancers (Basel) 2021;13:6110. [PMID: 34885217 DOI: 10.3390/cancers13236110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
229 Wu W, Liu Q, Zhang J, Zhao Y. Survey on the current status of the diagnosis and treatment of pancreatic cancer in public tertiary hospitals in China: a cross-sectional questionnaire-based, observational study. Journal of Pancreatology 2021;4:164-9. [DOI: 10.1097/jp9.0000000000000079] [Reference Citation Analysis]
230 Li N, Lu B, Luo C, Cai J, Lu M, Zhang Y, Chen H, Dai M. Incidence, mortality, survival, risk factor and screening of colorectal cancer: A comparison among China, Europe, and northern America. Cancer Lett 2021;522:255-68. [PMID: 34563640 DOI: 10.1016/j.canlet.2021.09.034] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 6.5] [Reference Citation Analysis]
231 Xie Y, Shi X, Chen Y, Wu B, Gong X, Lu W, Lin W. The intra-class heterogeneity of immunophenotyping and immune landscape in oesophageal cancer and clinical implications. Ann Med 2021;53:626-38. [PMID: 33860722 DOI: 10.1080/07853890.2021.1912385] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
232 Li J, Hu P, Shi J, Fan Y, Ren J, Chen H, Li N, Liao X, Liu Y, Du L, Wu N, Tang W, Zhang Y, Zou S, Pinsky P, Prorok P, Fagerstrom R, Taylor M, Kramer B, Dai M, He J. Results of the cancer screening feasibility study in China: a multicentered randomized controlled trial of lung and colorectal cancer screening. Journal of the National Cancer Center 2021;1:132-8. [DOI: 10.1016/j.jncc.2021.07.006] [Reference Citation Analysis]
233 Johnson D, Li L, Lee K, Lam K, Wong K, Ho W, Ma B. Total Neoadjuvant Therapy for High Risk Rectal Cancer in Western and Asian Populations – Current Evidence and Clinical Applications. Clinical Colorectal Cancer 2021. [DOI: 10.1016/j.clcc.2021.12.004] [Reference Citation Analysis]
234 Zeng H, Ran X, An L, Zheng R, Zhang S, Ji JS, Zhang Y, Chen W, Wei W, He J. Disparities in stage at diagnosis for five common cancers in China: a multicentre, hospital-based, observational study. The Lancet Public Health 2021;6:e877-87. [DOI: 10.1016/s2468-2667(21)00157-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
235 Pu Y, Li Q, Wang Y, Xu L, Qiao Q, Guo Y, Guo C. pERK-mediated IL8 secretion can enhance the migration, invasion, and cisplatin resistance of CD10-positive oral cancer cells. BMC Cancer 2021;21:1283. [PMID: 34847866 DOI: 10.1186/s12885-021-09025-7] [Reference Citation Analysis]
236 Lu Y, Li L. The Prognostic Value of Circulating Tumor DNA in Ovarian Cancer: A Meta-Analysis. Technol Cancer Res Treat 2021;20:15330338211043784. [PMID: 34817271 DOI: 10.1177/15330338211043784] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
237 Luo X, Xie Q, Shi Q, Miao Y, Yu Q, Yu H, Yin H, Leng X, Han Y, Zhou H. Profiling patient-reported symptom recovery from oesophagectomy for patients with oesophageal squamous cell carcinoma: a real-world longitudinal study. Support Care Cancer 2021. [PMID: 34817693 DOI: 10.1007/s00520-021-06711-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
238 Zhang X, Yang L, Liu S, Li H, Li Q, Cheng Y, Wang N, Ji J. Evaluation of Different Breast Cancer Screening Strategies for High-Risk Women in Beijing, China: A Real-World Population-Based Study. Front Oncol 2021;11:776848. [PMID: 34804981 DOI: 10.3389/fonc.2021.776848] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
239 Zhang Z, Liang G, Zhang P, Zhao Z, He Z, Luo F, Chen Z, Yang Z, Zhang Z, Xia T, Liu X, Zhang Y, Ye W. China county-based prostate specific antigen screening for prostate cancer and a cost-effective analysis. Transl Androl Urol 2021;10:3787-99. [PMID: 34804822 DOI: 10.21037/tau-21-779] [Reference Citation Analysis]
240 Yang C, Chen C, Xiao Q, Wang X, Shou Y, Tian X, Wang S, Li H, Liang Y, Shu J, Chen K, Sun M. Relationship Between PTEN and Angiogenesis of Esophageal Squamous Cell Carcinoma and the Underlying Mechanism. Front Oncol 2021;11:739297. [PMID: 34796109 DOI: 10.3389/fonc.2021.739297] [Reference Citation Analysis]
241 Li Y, Liu H, Sun Y, Li J, Chen Y, Zhang X, Wang J, Wu L, Shao D, Cao F. Characteristics and subtypes of depressive symptoms in Chinese female breast cancer patients of different ages: a cross-sectional study. AIMS Public Health 2021;8:691-703. [PMID: 34786429 DOI: 10.3934/publichealth.2021055] [Reference Citation Analysis]
242 Jiang L, Gong TT, Gao S, Li XQ, Liu FH, Wen ZY, Wei YF, Yan S, Hou R, Wu QJ. Pre-diagnosis Dairy Product Intake and Ovarian Cancer Mortality: Results From the Ovarian Cancer Follow-Up Study (OOPS). Front Nutr 2021;8:750801. [PMID: 34778342 DOI: 10.3389/fnut.2021.750801] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
243 Chen L, Zhou Q, Liu J, Zhang W. CTNNB1 Alternation Is a Potential Biomarker for Immunotherapy Prognosis in Patients With Hepatocellular Carcinoma. Front Immunol 2021;12:759565. [PMID: 34777372 DOI: 10.3389/fimmu.2021.759565] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
244 Yuan C, Tao Q, Wang J, Wang K, Zou S, Hu Z. Nomogram Based on Log Odds of Positive Lymph Nodes Predicting Cancer-Specific Survival in Patients With T3 and T4 Gallbladder Cancer After Radical Resection. Front Surg 2021;8:675661. [PMID: 34778352 DOI: 10.3389/fsurg.2021.675661] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
245 Su M, Yao N, Liu L, Cheng J, Sun X, Yue H, Zhang J. Older cancer survivors living with financial hardship in China: A qualitative study of family perspectives. Psychooncology 2021. [PMID: 34784087 DOI: 10.1002/pon.5854] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
246 Zheng Y, Wu J, Deng R, Lin C, Huang Y, Yang X, Wang C, Yang M, He Y, Lu J, Su X, Yan Q, Zhu Y, Guan X, Li Y, Yun J. G3BP2 regulated by the lncRNA LINC01554 facilitates esophageal squamous cell carcinoma metastasis through stabilizing HDGF transcript. Oncogene 2021. [PMID: 34782720 DOI: 10.1038/s41388-021-02073-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
247 Zhou X, Li TM, Luo JZ, Lan CL, Wei ZL, Fu TH, Liao XW, Zhu GZ, Ye XP, Peng T. CYP2C8 Suppress Proliferation, Migration, Invasion and Sorafenib Resistance of Hepatocellular Carcinoma via PI3K/Akt/p27kip1 Axis. J Hepatocell Carcinoma 2021;8:1323-38. [PMID: 34765572 DOI: 10.2147/JHC.S335425] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
248 Xu Y, Wei FX. A retrospective study of enteral nutrition on immune and inflammatory factors after liver cancer surgery. Medicine (Baltimore) 2021;100:e27718. [PMID: 34871264 DOI: 10.1097/MD.0000000000027718] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
249 Li Z, Li MY, Wang LL, Li L, Chen QY, Zhu YH, Li Y, Qin YR, Guan XY. The promoter hypermethylation of SULT2B1 accelerates esophagus tumorigenesis via downregulated PER1. Thorac Cancer 2021. [PMID: 34730281 DOI: 10.1111/1759-7714.14211] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
250 Gao Y, Xin L, Feng YD, Yao B, Lin H, Sun C, An W, Li ZS, Shi RH, Wang LW. Feasibility and Accuracy of Artificial Intelligence-Assisted Sponge Cytology for Community-Based Esophageal Squamous Cell Carcinoma Screening in China. Am J Gastroenterol 2021;116:2207-15. [PMID: 34546186 DOI: 10.14309/ajg.0000000000001499] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
251 Du Y, Li Y, Sidorenkov G, Vliegenthart R, Heuvelmans MA, Dorrius MD, Groen HJ, Liu S, Fan L, Ye Z, Greuter MJ, de Bock GH. Cost-effectiveness of lung cancer screening by low-dose CT in China: a micro-simulation study. Journal of the National Cancer Center 2021. [DOI: 10.1016/j.jncc.2021.11.002] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
252 Song D, Wei Y, Hu Y, Chen X, Zheng Y, Liu M, Wang Y, Zhou Y. Identification of prognostic biomarkers associated with tumor microenvironment in ceRNA network for esophageal squamous cell carcinoma: a bioinformatics study based on TCGA database. Discov Onc 2021;12. [DOI: 10.1007/s12672-021-00442-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
253 Li Y, Du Y, Huang Y, Zhao Y, Sidorenkov G, Vonder M, Cui X, Fan S, Dorrius MD, Vliegenthart R, Groen HJM, Liu S, Song F, Chen K, de Bock GH, Ye Z. Community-based lung cancer screening by low-dose computed tomography in China: First round results and a meta-analysis. Eur J Radiol 2021;144:109988. [PMID: 34695695 DOI: 10.1016/j.ejrad.2021.109988] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
254 Che YQ, Zhang Y, Li HB, Shen D, Cui W. Serum KLKB1 as a Potential Prognostic Biomarker for Hepatocellular Carcinoma Based on Data-Independent Acquisition and Parallel Reaction Monitoring. J Hepatocell Carcinoma 2021;8:1241-52. [PMID: 34676182 DOI: 10.2147/JHC.S325629] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
255 Zha Z, Lyu Y, Liu L, Dong T, Cheng B, Yang L, Liu Z. Association of cancer prevention awareness with liver cancer screening participation rates among a high-risk population: results from rural Anhui Province. Chinese Medical Journal 2022;135:499-501. [DOI: 10.1097/cm9.0000000000001735] [Reference Citation Analysis]
256 Zhang H, Teng J, Feng Y. Survival analysis based on the Bayesian method. 2021 China Automation Congress (CAC) 2021. [DOI: 10.1109/cac53003.2021.9728487] [Reference Citation Analysis]
257 Yao C, Lü Z, Zhang S, Kong L, Zhu Q, Cheng Y, Fang M. Research on clinical application of manual therapy to tumor-related adverse reactions. J Acupunct Tuina Sci . [DOI: 10.1007/s11726-021-1276-2] [Reference Citation Analysis]
258 Zhou Y, Li K, Zou X, Hua Z, Wang H, Bian W, Wang H, Chen F, Dai T. LncRNA DHRS4-AS1 ameliorates hepatocellular carcinoma by suppressing proliferation and promoting apoptosis via miR-522-3p/SOCS5 axis. Bioengineered 2021;12:10862-77. [PMID: 34666613 DOI: 10.1080/21655979.2021.1994719] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
259 Pan S, Gao Q, Chen Q, Liu P, Tan Y, Liu F, Xu H. Integrative analysis-based identification and validation of a prognostic immune cell infiltration-based model for patients with advanced gastric cancer. Int Immunopharmacol 2021;101:108258. [PMID: 34678693 DOI: 10.1016/j.intimp.2021.108258] [Reference Citation Analysis]
260 Chen W, Hou X, Hu Y, Huang G, Ye X, Nie S. A deep learning- and CT image-based prognostic model for the prediction of survival in non-small cell lung cancer. Med Phys 2021. [PMID: 34661294 DOI: 10.1002/mp.15302] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
261 Tan X, An Y, Chen C. Avoidant coping as mediator of the relationship between rumination and mental health among family caregivers of Chinese breast cancer patients. Eur J Cancer Care (Engl) 2021;:e13523. [PMID: 34658090 DOI: 10.1111/ecc.13523] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
262 Zhao M, Pu X, Yan YJ, Zhang S, Long X, Luo L, Li Z. The quality of life in women with cervical cancer and precancerous lesions of Han and ethnic minorities in Southwest China. BMC Cancer 2021;21:1110. [PMID: 34656093 DOI: 10.1186/s12885-021-08856-8] [Reference Citation Analysis]
263 Cui C, Wang L, Wang X. Health-related quality of life and social constraints among Chinese breast cancer patients: a cross-sectional study. Health Qual Life Outcomes 2021;19:238. [PMID: 34641883 DOI: 10.1186/s12955-021-01871-0] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
264 Geng H, Xing Y, Zhang J, Cao K, Ye M, Wang G, Liu C. Association between viral infection other than human papillomavirus and risk of esophageal carcinoma: a comprehensive meta-analysis of epidemiological studies. Arch Virol 2021. [PMID: 34636955 DOI: 10.1007/s00705-021-05268-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
265 Dai L, Cai X, Mugaanyi J, Liu Y, Mao S, Lu C, Lu C. Therapeutic effectiveness and safety of sintilimab-dominated triple therapy in unresectable hepatocellular carcinoma. Sci Rep 2021;11:19711. [PMID: 34611195 DOI: 10.1038/s41598-021-98937-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
266 Zhou Y, Lin B, Li K, Zhao Y, Sun Z, He C, Jha RK. Preparation of Near-Infrared/Photoacoustic Dual-Mode Imaging and Photothermal/Chemo Synergistic Theranostic Nanoparticles and Their Imaging and Treating of Hepatic Carcinoma. Front Oncol 2021;11:750807. [PMID: 34604095 DOI: 10.3389/fonc.2021.750807] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
267 An M, Xing X, Chen T. Long non-coding RNA UCA1 enhances cervical cancer cell proliferation and invasion by regulating microRNA-299-3p expression. Oncol Lett 2021;22:772. [PMID: 34589151 DOI: 10.3892/ol.2021.13033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
268 Hu Q, Pan S, Guo Z. A novel pN3 gastric cancer staging system with superior prognostic utility based upon the examination of over 31 lymph nodes: a propensity score-matching analysis. BMC Gastroenterol 2021;21:352. [PMID: 34563111 DOI: 10.1186/s12876-021-01928-w] [Reference Citation Analysis]
269 Ma J, Wang Y, Yu S, Zhou C, Wang D, Tang D, Jiang G, Zhang Y. Use of the modified Clavien‑Dindo classification to determine the risk factors for early complications following radical gastrectomy and the effect of such complications on long‑term prognosis. World Acad Sci J 2021;3. [DOI: 10.3892/wasj.2021.130] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
270 Huang Z, Li B, Guo Y, Wu L, Kou F, Yang L. Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma. Front Immunol 2021;12:723172. [PMID: 34539658 DOI: 10.3389/fimmu.2021.723172] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
271 Ren Z, Hou X, Xue Z, Zhang L, Wang B, Wen J, Chu X. The relationship between the number of circulating tumor cells and the prognosis in patients with esophageal squamous cell carcinoma. J Gastrointest Oncol 2021;12:1265-76. [PMID: 34532086 DOI: 10.21037/jgo-21-409] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
272 Yang F, Fu Y, Kumar A, Chen M, Si L, Rojanasarot S. Cost-effectiveness analysis of camrelizumab in the second-line treatment for advanced or metastatic esophageal squamous cell carcinoma in China. Ann Transl Med 2021;9:1226. [PMID: 34532363 DOI: 10.21037/atm-21-1803] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
273 Hu X, Jia J, Yang Z, Chen S, Xue J, Duan S, Yang P, Peng S, Yang L, Yuan L, Bao G. PLCE1 Polymorphisms Are Associated With Gastric Cancer Risk: The Changes in Protein Spatial Structure May Play a Potential Role. Front Genet 2021;12:714915. [PMID: 34531897 DOI: 10.3389/fgene.2021.714915] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
274 Li Y, Piao J, Li M. Secular Trends in the Epidemiologic Patterns of Thyroid Cancer in China Over Three Decades: An Updated Systematic Analysis of Global Burden of Disease Study 2019 Data. Front Endocrinol (Lausanne) 2021;12:707233. [PMID: 34526968 DOI: 10.3389/fendo.2021.707233] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
275 Niu C, Liu Y, Wang J, Liu Y, Zhang S, Zhang Y, Zhang L, Zhao D, Liu F, Chao L, Wang X, Zhang C, Song G, Zhang Z, Li Y, Yan Z, Wen Y, Ge Y, Zang Z, Feng W, Zhang H, Tao L, Nakyeyune R, Shen Y, Shao Y, Guo X, Miles T, Yang A, Liu F, Wang G. Risk factors for esophageal squamous cell carcinoma and its histological precursor lesions in China: a multicenter cross-sectional study. BMC Cancer 2021;21:1034. [PMID: 34530751 DOI: 10.1186/s12885-021-08764-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
276 Li N, Yang F, Liu DY, Guo JT, Ge N, Sun SY. Scoparone inhibits pancreatic cancer through PI3K/Akt signaling pathway. World J Gastrointest Oncol 2021; 13(9): 1164-1183 [PMID: 34616521 DOI: 10.4251/wjgo.v13.i9.1164] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
277 Li Y, He P, Liu Y, Qi M, Dong W. Combining Sodium Butyrate With Cisplatin Increases the Apoptosis of Gastric Cancer In Vivo and In Vitro via the Mitochondrial Apoptosis Pathway. Front Pharmacol 2021;12:708093. [PMID: 34512341 DOI: 10.3389/fphar.2021.708093] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
278 Qu X, Shi Z, Guo J, Guo C, Qiu J, Hua K. Identification of a novel six-gene signature with potential prognostic and therapeutic value in cervical cancer. Cancer Med 2021;10:6881-96. [PMID: 34498424 DOI: 10.1002/cam4.4054] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
279 Qin Y, Zhou J, Fan Z, Gu J, Li X, Lin D, Deng D, Wei W. Evaluation of the Impact of Intratumoral Heterogeneity of Esophageal Cancer on Pathological Diagnosis and P16 Methylation and the Representativity of Endoscopic Biopsy. Front Oncol 2021;11:683876. [PMID: 34485122 DOI: 10.3389/fonc.2021.683876] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
280 Yan R, Che B, Lv B, Wu P, Lu X, Zhang Y, Wang J, Yu J. The association between physical activity, sedentary time and health-related quality of life in cancer survivors. Health Qual Life Outcomes 2021;19:213. [PMID: 34488798 DOI: 10.1186/s12955-020-01575-x] [Reference Citation Analysis]
281 Xu L, Zhou C, Ling Y, Ding H, Wang Q, Wu Y, Qian Y, He B, Ni T. Effects of Short-Term Unsupervised Exercise, Based on Smart Bracelet Monitoring, on Body Composition in Patients Recovering from Breast Cancer. Integr Cancer Ther 2021;20:15347354211040780. [PMID: 34467791 DOI: 10.1177/15347354211040780] [Reference Citation Analysis]
282 Guo C, Zou X, Hong Z, Sun J, Xiao W, Sun K, Li X, Shen Y, Liang T, Bai X. Preoperative transarterial chemoembolization for barcelona clinic liver cancer stage A/B hepatocellular carcinoma beyond the milan criteria: a propensity score matching analysis. HPB (Oxford) 2021;23:1427-38. [PMID: 33715958 DOI: 10.1016/j.hpb.2021.02.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
283 Xu S, Xiang C, Wu J, Teng Y, Wu Z, Wang R, Lu B, Zhan Z, Wu H, Zhang J. Tongue Coating Bacteria as a Potential Stable Biomarker for Gastric Cancer Independent of Lifestyle. Dig Dis Sci 2021;66:2964-80. [PMID: 33044677 DOI: 10.1007/s10620-020-06637-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
284 Zhang H, Yin F, Chen M, Qi A, Yang L, Cui W, Yang S, Wen G. [Predicting postoperative recurrence of stage Ⅰ-Ⅲ renal clear cell carcinoma based on preoperative CT radiomics feature nomogram]. Nan Fang Yi Ke Da Xue Xue Bao 2021;41:1358-65. [PMID: 34658350 DOI: 10.12122/j.issn.1673-4254.2021.09.10] [Reference Citation Analysis]
285 Wang DK, Zuo Q, He QY, Li B. Targeted Immunotherapies in Gastrointestinal Cancer: From Molecular Mechanisms to Implications. Front Immunol 2021;12:705999. [PMID: 34447376 DOI: 10.3389/fimmu.2021.705999] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
286 Hu C, Zhang Q, Shi H. Nutrition status of patients with common cancer in China: gap, mission and challenge. Sci China Life Sci 2021;64:1980-3. [PMID: 34406571 DOI: 10.1007/s11427-021-1954-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
287 Xia R, Zeng H, Liu W, Xie L, Shen M, Li P, Li H, Wei W, Chen W, Zhuang G. Estimated Cost-effectiveness of Endoscopic Screening for Upper Gastrointestinal Tract Cancer in High-Risk Areas in China. JAMA Netw Open 2021;4:e2121403. [PMID: 34402889 DOI: 10.1001/jamanetworkopen.2021.21403] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
288 Wang YQ, Li HZ, Gong WW, Chen YY, Zhu C, Wang L, Zhong JM, Du LB. Cancer incidence and mortality in Zhejiang Province, Southeast China, 2016: a population-based study. Chin Med J (Engl) 2021;134:1959-66. [PMID: 34334631 DOI: 10.1097/CM9.0000000000001666] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
289 Zhu T, Yang Q, Shao J, Chen Z, Cai B, Mao G. Pyk2 level is a novel prognostic marker for patients with esophageal squamous cell carcinoma after radical surgery. Virchows Arch 2021. [PMID: 34313839 DOI: 10.1007/s00428-021-03153-y] [Reference Citation Analysis]
290 Liu SR, Yan Q, Lin HM, Shi GZ, Cao Y, Zeng H, Liu C, Zhang R. Anti-programmed cell death ligand 1-based immunotherapy in recurrent hepatocellular carcinoma with inferior vena cava tumor thrombus and metastasis: Three case reports. World J Clin Cases 2021; 9(21): 5988-5998 [PMID: 34368318 DOI: 10.12998/wjcc.v9.i21.5988] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
291 Zhang R, Li H, Li N, Shi JF, Li J, Chen HD, Yu YW, Qin C, Ren JS, Chen WQ, He J. Risk factors for gastric cancer: a large-scale, population-based case-control study. Chin Med J (Engl) 2021;134:1952-8. [PMID: 34310399 DOI: 10.1097/CM9.0000000000001652] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
292 Zhu W, Xu J, Chen Z, Jiang J. Analyzing Roles of NUSAP1 From Clinical, Molecular Mechanism and Immune Perspectives in Hepatocellular Carcinoma. Front Genet 2021;12:689159. [PMID: 34354737 DOI: 10.3389/fgene.2021.689159] [Reference Citation Analysis]
293 Wang J, Zhao J, Zhang C, Zhang Y, Jiang N, Wei X, Wang J, Yu J. Comorbidity, lifestyle factors, and sexual satisfaction among Chinese cancer survivors. Cancer Med 2021;10:6058-69. [PMID: 34254466 DOI: 10.1002/cam4.4118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
294 Han C, Ye S, Hu C, Shen L, Qin Q, Bai Y, Yang S, Bai C, Zang A, Jiao S, Bai L. Clinical Activity and Safety of Penpulimab (Anti-PD-1) With Anlotinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: An Open-Label, Multicenter, Phase Ib/II Trial (AK105-203). Front Oncol 2021;11:684867. [PMID: 34327136 DOI: 10.3389/fonc.2021.684867] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
295 Huang RL, Liu Q, Wang YX, Zou JY, Hu LF, Wang W, Huang YH, Wang YZ, Zeng B, Zeng X, Zeng Y. Awareness, attitude and barriers of colorectal cancer screening among high-risk populations in China: a cross-sectional study. BMJ Open 2021;11:e045168. [PMID: 34253663 DOI: 10.1136/bmjopen-2020-045168] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
296 Ban Y, Li M, Yu M, Wu H. The effect of fear of progression on quality of life among breast cancer patients: the mediating role of social support. Health Qual Life Outcomes 2021;19:178. [PMID: 34253195 DOI: 10.1186/s12955-021-01816-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
297 Bai XM, Yang W. Radiofrequency ablation of hepatocellular carcinoma: Prognostic factors and recent advances. Shijie Huaren Xiaohua Zazhi 2021; 29(13): 677-683 [DOI: 10.11569/wcjd.v29.i13.677] [Reference Citation Analysis]
298 Sun C, Li K, Xu H, Wang X, Qin P, Wang S, Liang B, Xu L. Association of healthy lifestyle score with all-cause mortality and life expectancy: a city-wide prospective cohort study of cancer survivors. BMC Med 2021;19:158. [PMID: 34229666 DOI: 10.1186/s12916-021-02024-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
299 Wu H, Jiang Q, Luo K, Zhu C, Xie M, Wang S, Fei Z, Zhao J. Synthesis of iridium-based nanocomposite with catalase activity for cancer phototherapy. J Nanobiotechnology 2021;19:203. [PMID: 34233696 DOI: 10.1186/s12951-021-00948-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
300 Mao S, Yu X, Yang Y, Shan Y, Mugaanyi J, Wu S, Lu C. Preoperative nomogram for microvascular invasion prediction based on clinical database in hepatocellular carcinoma. Sci Rep 2021;11:13999. [PMID: 34234239 DOI: 10.1038/s41598-021-93528-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
301 Chinese Society of Clinical Oncology, Expert Committee on Non-small Cell Lung Cancer. [Chinese Expert Consensus on Next Generation Sequencing Diagnosis 
for Non-small Cell Lung Cancer (2020 Edition)]. Zhongguo Fei Ai Za Zhi 2020;23:741-61. [PMID: 32957170 DOI: 10.3779/j.issn.1009-3419.2020.101.45] [Reference Citation Analysis]
302 Wang P, Yang S, Dai S, Ni Q, Liu H, Yu L, Lu K, Han G, Huang J. Expression and Clinical Value of LncRNA GAPLINC in Esophageal Squamous Cell Carcinoma. Onco Targets Ther 2021;14:4039-45. [PMID: 34262290 DOI: 10.2147/OTT.S299394] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
303 Bu X, Ng PH, Xu W, Cheng Q, Chen PQ, Cheng AS, Liu X. The Effectiveness of Virtual Reality–Based Interventions in Rehabilitation Management of Breast Cancer Survivors: Systematic Review and Meta-analysis (Preprint).. [DOI: 10.2196/preprints.31395] [Reference Citation Analysis]
304 Li H, Ding C, Zeng H, Zheng R, Cao M, Ren J, Shi J, Sun D, He S, Yang Z, Yu Y, Zhang Z, Sun X, Guo G, Song G, Wei W, Chen W, He J. Improved esophageal squamous cell carcinoma screening effectiveness by risk-stratified endoscopic screening: evidence from high-risk areas in China. Cancer Commun (Lond) 2021;41:715-25. [PMID: 34146456 DOI: 10.1002/cac2.12186] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
305 Qin S, Yang L, Kong S, Xu Y, Liang B, Ju S. LncRNA HCP5 : A Potential Biomarker for Diagnosing Gastric Cancer. Front Oncol 2021;11:684531. [PMID: 34222007 DOI: 10.3389/fonc.2021.684531] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
306 Huang C, Liang X, Du S, He J, Bai Q, Feng X, Liu X, Tian X, Wang J. Therapeutic Effect and Cost-Benefit Analysis of Three Different Nutritional Schemes for Esophageal Cancer Patients in the Early Post-operative Period. Front Nutr 2021;8:651596. [PMID: 34222299 DOI: 10.3389/fnut.2021.651596] [Reference Citation Analysis]
307 Li M, Gao J, Li M, Wang L. The assessment of returning to work following treatment and the associated personal, disease, and treatment factors among breast cancer survivors in central China. Support Care Cancer 2021. [PMID: 34132883 DOI: 10.1007/s00520-021-06354-y] [Reference Citation Analysis]
308 Zhao L, Niu P, Zhao D, Chen Y. Regional and racial disparity in proximal gastric cancer survival outcomes 1996-2016: Results from SEER and China National Cancer Center database. Cancer Med 2021;10:4923-38. [PMID: 34105890 DOI: 10.1002/cam4.4033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
309 Xing JL, Wang YX, Du SD. Application and research progress of in vitro liver cancer cell culture models. Shijie Huaren Xiaohua Zazhi 2021; 29(11): 563-570 [DOI: 10.11569/wcjd.v29.i11.563] [Reference Citation Analysis]
310 Lin X, Wang H, Rong X, Huang R, Peng Y. Exploring stroke risk and prevention in China: insights from an outlier. Aging (Albany NY) 2021;13:15659-73. [PMID: 34086602 DOI: 10.18632/aging.203096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
311 Wang S, Huang HY, Wu D, Fang H, Ying J, Bai Y, Yu Y, Fang Y, Jiang N, Sun C, Yu A, Fan Q, Xing S, Ni Y, Zhang W, Wu C, Ji X, Wang H, Guo Y, Tang Q, Wang Y, Tang Y, Li N. Platform study of genotyping-guided precision medicine for rare solid tumours: a study protocol for a phase II, non-randomised, 18-month, open-label, multiarm, single-centre clinical trial testing the safety and efficacy of multiple Chinese-approved targeted drugs and PD-1 inhibitors in the treatment of metastatic rare tumours. BMJ Open 2021;11:e044543. [PMID: 34083331 DOI: 10.1136/bmjopen-2020-044543] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
312 Bian R, Dang W, Song X, Liu L, Jiang C, Yang Y, Li Y, Li L, Li X, Hu Y, Bao R, Liu Y. Rac GTPase activating protein 1 promotes gallbladder cancer via binding DNA ligase 3 to reduce apoptosis. Int J Biol Sci 2021;17:2167-80. [PMID: 34239347 DOI: 10.7150/ijbs.58857] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
313 Rao W, Liu FG, Jiang YP, Xie M. De novo multiple primary carcinomas in a patient after liver transplantation: A case report. World J Clin Cases 2021; 9(15): 3765-3772 [PMID: 34046481 DOI: 10.12998/wjcc.v9.i15.3765] [Reference Citation Analysis]
314 Jia Z, Liang N, Li S. [Application of Organoids in Lung Cancer Precision Medicine]. Zhongguo Fei Ai Za Zhi 2020;23:615-20. [PMID: 32702796 DOI: 10.3779/j.issn.1009-3419.2020.101.20] [Reference Citation Analysis]
315 Shen L, Guo J, Zhang Q, Pan H, Yuan Y, Bai Y, Liu T, Zhou Q, Zhao J, Shu Y, Huang X, Wang S, Wang J, Zhou A, Ye D, Sun T, Gao Y, Yang S, Wang Z, Li J, Wu YL. Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study. J Immunother Cancer 2020;8:e000437. [PMID: 32561638 DOI: 10.1136/jitc-2019-000437] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 21.5] [Reference Citation Analysis]
316 Hanis TM, Yaacob NM, Mohd Hairon S, Abdullah S. Net survival differences of breast cancer between stages at diagnosis and age groups in the east coast region of West Malaysia: a retrospective cohort study. BMJ Open 2021;11:e043642. [PMID: 34006546 DOI: 10.1136/bmjopen-2020-043642] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
317 Sun L, Ke X, Wang D, Yin H, Jin B, Xu H, Du S, Xu Y, Zhao H, Lu X, Sang X, Zhong S, Yang H, Mao Y. Prognostic Value of the Albumin-to-γ-glutamyltransferase Ratio for Gallbladder Cancer Patients and Establishing a Nomogram for Overall Survival. J Cancer 2021;12:4172-82. [PMID: 34093818 DOI: 10.7150/jca.49242] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
318 Henglian L, Jiajun W, Caixia W, Gang L, Min X. Analysis of related risk factors of lung metastasis after laparoscopic radical hysterectomy of cervical cancer. Medicine (Baltimore) 2021;100:e24480. [PMID: 33950913 DOI: 10.1097/MD.0000000000024480] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
319 Liu M, Zhou R, Guo C, Xu R, Liu A, Yang H, Li F, Duan L, Shen L, Wu Q, Liu Z, Liu F, Liu Y, Pan Y, Cai H, Weiss NS, He Z, Ke Y. Size of Lugol-unstained lesions as a predictor for risk of progression in premalignant lesions of the esophagus. Gastrointest Endosc 2021;93:1065-1073.e3. [PMID: 32950597 DOI: 10.1016/j.gie.2020.09.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
320 Wang X, Xing Z, Xu H, Yang H, Xing T. Development and validation of epithelial mesenchymal transition-related prognostic model for hepatocellular carcinoma. Aging (Albany NY) 2021;13:13822-45. [PMID: 33929972 DOI: 10.18632/aging.202976] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
321 Gu ZT, Li ZZ, Wang CF. Advances in research of extracellular mechanisms underlying gemcitabine resistance in pancreatic cancer. Shijie Huaren Xiaohua Zazhi 2021; 29(8): 421-434 [DOI: 10.11569/wcjd.v29.i8.421] [Reference Citation Analysis]
322 Ren H, Zhang JW, Lan ZM, Du YX, Qiu GT, Zhang LP, Gu ZT, Li ZZ, Li G, Shao HB, Ju ZJ, Yu W, Qu BL, Xu K, Wang CF. Intraoperative radiotherapy vs concurrent chemoradiotherapy in the treatment of patients with locally advanced pancreatic cancer. Pancreatology 2021:S1424-3903(21)00146-0. [PMID: 33933371 DOI: 10.1016/j.pan.2021.04.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
323 Liu S, Tang Q, Huang J, Zhan M, Zhao W, Yang X, Li Y, Qiu L, Zhang F, Lu L, He X. Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data. Aging (Albany NY) 2021;13:11257-80. [PMID: 33820866 DOI: 10.18632/aging.202811] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
324 Wang Z, Yao Y, Mai Z, Lin W, Huang Y, Jin Y, Luo H, Zhang D, Wang F, Wang F, Chen G, Ding P, Yuan Y, Li Y, Huang J, Pan Z, Xu R. Temporal Change in Treatment Patterns of Metastatic Colorectal Cancer and Its Association with Patient Survival: A Retrospective Cohort Study Based on an Intelligent Big-Data Platform. Engineering 2021;7:526-33. [DOI: 10.1016/j.eng.2020.10.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
325 Liu L, Wu J, Shi M, Wang F, Lu H, Liu J, Chen W, Yu G, Liu D, Yang J, Luo Q, Ni Y, Jin X, Jin X, Chen W. New metabolic alterations and predictive marker pipecolic acid in sera for esophageal squamous cell carcinoma.. [DOI: 10.1101/2021.03.31.437882] [Reference Citation Analysis]
326 Shi J, Li D, Liang D, He Y. Epidemiology and prognosis in young lung cancer patients aged under 45 years old in northern China. Sci Rep 2021;11:6817. [PMID: 33767239 DOI: 10.1038/s41598-021-86203-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
327 Zhu D, Shi X, Nicholas S, Ma Y, He P. Estimated annual prevalence, medical service utilization and direct costs of lung cancer in urban China. Cancer Med 2021;10:2914-23. [PMID: 33749141 DOI: 10.1002/cam4.3845] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
328 Ye H, Li T, Wang H, Wu J, Yi C, Shi J, Wang P, Song C, Dai L, Jiang G, Huang Y, Yu Y, Li J. TSPAN1, TMPRSS4, SDR16C5, and CTSE as Novel Panel for Pancreatic Cancer: A Bioinformatics Analysis and Experiments Validation. Front Immunol 2021;12:649551. [PMID: 33815409 DOI: 10.3389/fimmu.2021.649551] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
329 Guan X, Liu C, Zhou T, Ma Z, Zhang C, Wang B, Yao Y, Fan X, Li Z, Zhang Y. Survival and prognostic factors of patients with esophageal fistula in advanced esophageal squamous cell carcinoma. Biosci Rep 2020;40:BSR20193379. [PMID: 31894852 DOI: 10.1042/BSR20193379] [Cited by in Crossref: 12] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
330 Shen Y, Shao Y, Niu C, Ruan X, Zang Z, Nakyeyune R, Guo X, Liu F. Systematic Identification of circRNA-miRNA-mRNA Regulatory Network in Esophageal Squamous Cell Carcinoma. Front Genet 2021;12:580390. [PMID: 33747034 DOI: 10.3389/fgene.2021.580390] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
331 Xia C, Xu X, Zhao X, Hu S, Qiao Y, Zhang Y, Hutubessy R, Basu P, Broutet N, Jit M, Zhao F. Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study. BMC Med 2021;19:62. [PMID: 33653331 DOI: 10.1186/s12916-021-01930-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
332 Tian H, Hu Y, Li Q, Lei L, Liu Z, Liu M, Guo C, Liu F, Liu Y, Pan Y, Dos-Santos-Silva I, He Z, Ke Y. Estimating cancer survival and prevalence with the Medical-Insurance-System-based Cancer Surveillance System (MIS-CASS): An empirical study in China. EClinicalMedicine 2021;33:100756. [PMID: 33718848 DOI: 10.1016/j.eclinm.2021.100756] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
333 Zeng X, Sui M, Liu R, Qian X, Li W, Zheng E, Yang J, Li J, Huang W, Yang H, Yu H, Luo N. Assessment of the health utility of patients with leukemia in China. Health Qual Life Outcomes 2021;19:65. [PMID: 33639980 DOI: 10.1186/s12955-021-01711-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
334 Li LL, Su YX, Mao Y, Jiang PY, Chu XL, Xue P, Jia BH, Zhu SJ. The Effectiveness and Safety of Cinobufotalin Injection as an Adjunctive Treatment for Lung Cancer: A Meta-Analysis of Randomized Controlled Trials. Evid Based Complement Alternat Med 2021;2021:8852261. [PMID: 33628320 DOI: 10.1155/2021/8852261] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
335 Liao X, Huang R, Wang X, Huang K, Yang C, Zhou X, Han C, Su H, Ye X, Liu K, Zhu G, Peng T. UXT antisense RNA 1 sever as a novel prognostic long non-coding RNA in early stage pancreatic ductal adenocarcinoma patients after receiving pancreaticoduodenectomy. J Cancer 2021;12:2122-39. [PMID: 33754011 DOI: 10.7150/jca.46084] [Reference Citation Analysis]
336 Huang T, Wagner AK, Bai L, Huang C, Guan X, Shi L. Anticancer medicines in China: Trends in daily therapy cost and relative procurement volume and spending. Cancer Commun (Lond) 2021;41:345-8. [PMID: 33609064 DOI: 10.1002/cac2.12144] [Reference Citation Analysis]
337 He F, Wang J, Liu L, Qin X, Wan Z, Li W, Ping Z. Esophageal cancer: trends in incidence and mortality in China from 2005 to 2015. Cancer Med 2021;10:1839-47. [PMID: 33594825 DOI: 10.1002/cam4.3647] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
338 Keykhaei M, Masinaei M, Mohammadi E, Azadnajafabad S, Rezaei N, Saeedi Moghaddam S, Rezaei N, Nasserinejad M, Abbasi-Kangevari M, Malekpour MR, Ghamari SH, Haghshenas R, Koliji K, Kompani F, Farzadfar F. A global, regional, and national survey on burden and Quality of Care Index (QCI) of hematologic malignancies; global burden of disease systematic analysis 1990-2017. Exp Hematol Oncol 2021;10:11. [PMID: 33557940 DOI: 10.1186/s40164-021-00198-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 12.0] [Reference Citation Analysis]
339 Chen JG, Zhu J, Zhang YH, Chen YS, Lu JH, Zhu YR, Chen HZ, Shen AG, Wang GR, Groopman JD, Kensler TW. Liver cancer mortality over six decades in an epidemic area: what we have learned. PeerJ 2021;9:e10600. [PMID: 33604165 DOI: 10.7717/peerj.10600] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
340 Wang X, Ge X, Wang H, Huang J, Song Q, Xu C, Jiang Z, Su J, Wang H, Tan L, Jiang D, Hou Y. SOX2 amplification and chromosome 3 gain significantly impact prognosis in esophageal squamous cell carcinoma. Ann Transl Med 2021;9:321. [PMID: 33708948 DOI: 10.21037/atm-20-1290] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
341 Qiu J, Hou S, Li P, Huang L. Medical professionals' knowledge of the use of external breast prostheses among breast cancer patients in China-a cross-sectional study. Gland Surg 2021;10:595-606. [PMID: 33708543 DOI: 10.21037/gs-20-657] [Reference Citation Analysis]
342 Chen R, Liu Y, Song G, Li B, Zhao D, Hua Z, Wang X, Li J, Hao C, Zhang L, Liu S, Wang J, Zhou J, Zhang Y, Li B, Li Y, Feng X, Li L, Dong Z, Wei W, Wang G. Effectiveness of one-time endoscopic screening programme in prevention of upper gastrointestinal cancer in China: a multicentre population-based cohort study. Gut 2021;70:251-60. [PMID: 32241902 DOI: 10.1136/gutjnl-2019-320200] [Cited by in Crossref: 24] [Cited by in F6Publishing: 36] [Article Influence: 12.0] [Reference Citation Analysis]
343 Cao Y, Zhao G, Yuan M, Liu X, Ma Y, Cao Y, Miao B, Zhao S, Li D, Xiong S, Zheng M, Fei S. KCNQ5 and C9orf50 Methylation in Stool DNA for Early Detection of Colorectal Cancer. Front Oncol 2020;10:621295. [PMID: 33585248 DOI: 10.3389/fonc.2020.621295] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
344 Yang Y, Zhou M, Zeng X, Wang C. The burden of oral cancer in China, 1990-2017: an analysis for the Global Burden of Disease, Injuries, and Risk Factors Study 2017. BMC Oral Health 2021;21:44. [PMID: 33509185 DOI: 10.1186/s12903-020-01386-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
345 Kang N, Fang Y, Zhu H, Shi Z, Chen L, Lu Y, Wang H, Lu J, Liu W, Hu K. Prognostic Value of CT Imaging-Based Tumor Volume in Patients With Non-Surgical Esophageal Squamous Cell Carcinoma. Front Oncol 2020;10:602681. [PMID: 33575213 DOI: 10.3389/fonc.2020.602681] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
346 Chen Z, Zhu D, Hu X, Gao G. Subjective life expectancy and associated factors among cancer survivors over 45 years old: evidence from the CHARLS. Qual Life Res 2021;30:1571-82. [PMID: 33462662 DOI: 10.1007/s11136-020-02751-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
347 Zhang L, Jia W, Ji N, Li D, Xiao D, Shan GL, Wang T, Xiao X. Construction of the National Brain Tumor Registry of China for better management and more efficient use of data: a protocol. BMJ Open 2021;11:e040055. [PMID: 33455925 DOI: 10.1136/bmjopen-2020-040055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
348 Liu L, Li D, Shu J, Wang L, Zhang F, Zhang C, Yu H, Chen M, Li Z, Guo X. Protein Glycopatterns in Bronchoalveolar Lavage Fluid as Novel Potential Biomarkers for Diagnosis of Lung Cancer. Front Oncol 2020;10:568433. [PMID: 33520694 DOI: 10.3389/fonc.2020.568433] [Reference Citation Analysis]
349 Wang YX, Zhang X, Ma QY, Hu LD, Zhang X, Wang Y, Xu L, Yang CH, Tan C, Kong XY, Ding J, Meng LH. Adaptive resistance to PI3Kα-selective inhibitor CYH33 is mediated by genomic and transcriptomic alterations in ESCC cells. Cell Death Dis 2021;12:85. [PMID: 33446653 DOI: 10.1038/s41419-020-03370-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
350 Pang X, Wang Y, Miao B, Fei S, Chen W. Regulation of ARL2 in colorectal cancer cell proliferation and tumorigenicity, and its negative association with AXL. Oncol Lett 2021;21:196. [PMID: 33574935 DOI: 10.3892/ol.2021.12457] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
351 Song Q, Shi F, Xiao S, Li Y, Zhao Y, Chang H. The integration of proportion and cell counts of stromal, not intratumoral, PD-1+ tumor-infiltrating lymphocytes has prognostic significance in esophageal squamous cell carcinoma. Dis Esophagus 2021;34:doaa035. [PMID: 32395761 DOI: 10.1093/dote/doaa035] [Reference Citation Analysis]
352 Shen Y, Xie S, Zhao L, Song G, Shao Y, Hao C, Niu C, Ruan X, Zang Z, Nakyeyune R, Liu F, Wei W. Estimating Individualized Absolute Risk for Esophageal Squamous Cell Carcinoma: A Population-Based Study in High-Risk Areas of China. Front Oncol 2020;10:598603. [PMID: 33489898 DOI: 10.3389/fonc.2020.598603] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
353 李 锦. Effect of Lymphocyte Subsets Variation on Progression-Free Survival of NSCLC during Peri-Radiotherapy Period. ACM 2021;11:4283-4289. [DOI: 10.12677/acm.2021.119627] [Reference Citation Analysis]
354 Zhao W. Early diagnosis and precise treatment of hepatocellular carcinoma. E3S Web Conf 2021;271:03012. [DOI: 10.1051/e3sconf/202127103012] [Reference Citation Analysis]
355 黄 汉. Surgical Treatment of Gallbladder Carcinoma: Current Situation and Progress. ACM 2021;11:4661-4667. [DOI: 10.12677/acm.2021.1110685] [Reference Citation Analysis]
356 Liu C, Shi J, Wang H, Yan X, Wang L, Ren J, Parascandola M, Chen W, Dai M. Population-level economic burden of lung cancer in China: Provisional prevalence-based estimations, 2017-2030. Chin J Cancer Res 2021;33:79-92. [PMID: 33707931 DOI: 10.21147/j.issn.1000-9604.2021.01.09] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
357 Chen J, Wang Y, Zhao D, Zhang L, Zhang W, Fan J, Li J, Zhan Q. Chrysin serves as a novel inhibitor of DGKα/FAK interaction to suppress the malignancy of esophageal squamous cell carcinoma (ESCC). Acta Pharm Sin B 2021;11:143-55. [PMID: 33532186 DOI: 10.1016/j.apsb.2020.07.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
358 徐 翔. Significance of Ki-67 Expression in Hepatocellular Carcinoma with Microvascular Tumor Thrombus. ACM 2021;11:2507-2513. [DOI: 10.12677/acm.2021.116360] [Reference Citation Analysis]
359 Fan X, Qin X, Zhang Y, Li Z, Zhou T, Zhang J, You W, Li W, Pan K. Screening for gastric cancer in China: Advances, challenges and visions. Chin J Cancer Res 2021;33:168-80. [PMID: 34158737 DOI: 10.21147/j.issn.1000-9604.2021.02.05] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
360 Chen W, Li H, Zheng R, Ren J, Shi J, Cao M, Sun D, Sun X, Cao X, Zhou J, Luo P, Wang J, Ma H, Shao T, Zhao C, He S, Sun D, Xu Y, Wu P, Zeng H, Li J, He J. An initial screening strategy based on epidemiologic information in esophageal cancer screening: a prospective evaluation in a community-based cancer screening cohort in rural China. Gastrointest Endosc 2021;93:110-118.e2. [PMID: 32504698 DOI: 10.1016/j.gie.2020.05.052] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
361 He S, Yu T, Khadaroo PA, Cai L, Chu Y, Wei F, Liang X. A Comparison Between the Prognosis of Simultaneous and Salvage Radical Resection in Incidental Gallbladder Cancer. Cancer Manag Res 2020;12:13469-78. [PMID: 33408519 DOI: 10.2147/CMAR.S286292] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
362 Yang Q, Qin J, Sun G, Qiu C, Jiang D, Ye H, Wang X, Dai L, Zhu J, Wang P, Zhang J. Discovery and Validation of Serum Autoantibodies Against Tumor-Associated Antigens as Biomarkers in Gastric Adenocarcinoma Based on the Focused Protein Arrays. Clin Transl Gastroenterol 2020;12:e00284. [PMID: 33346593 DOI: 10.14309/ctg.0000000000000284] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
363 Li N, Hu Y, Zhang X, Liu Y, He Y, van der Zee AGJ, Schuuring E, Wisman GBA. DNA methylation markers as triage test for the early identification of cervical lesions in a Chinese population. Int J Cancer 2021;148:1768-77. [PMID: 33300604 DOI: 10.1002/ijc.33430] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
364 Tu Y, Wu Y, Lu Y, Bi X, Chen T. Development of risk prediction models for lung cancer based on tumor markers and radiological signs. J Clin Lab Anal 2021;35:e23682. [PMID: 33325592 DOI: 10.1002/jcla.23682] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
365 Sun D, Li H, Cao M, He S, Lei L, Peng J, Chen W. Cancer burden in China: trends, risk factors and prevention. Cancer Biol Med 2020;17:879-95. [PMID: 33299641 DOI: 10.20892/j.issn.2095-3941.2020.0387] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 13.0] [Reference Citation Analysis]
366 Zhang F, Zhong LZ, Zhao X, Dong D, Yao JJ, Wang SY, Liu Y, Zhu D, Wang Y, Wang GJ, Wang YM, Li D, Wei J, Tian J, Shan H. A deep-learning-based prognostic nomogram integrating microscopic digital pathology and macroscopic magnetic resonance images in nasopharyngeal carcinoma: a multi-cohort study. Ther Adv Med Oncol 2020;12:1758835920971416. [PMID: 33403013 DOI: 10.1177/1758835920971416] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
367 Han B, Ding H, Zhao S, Zhang Y, Wang J, Zhang Y, Gu J. Potential Role of Adjuvant Lenvatinib in Improving Disease-Free Survival for Patients With High-Risk Hepatitis B Virus-Related Hepatocellular Carcinoma Following Liver Transplantation: A Retrospective, Case Control Study. Front Oncol 2020;10:562103. [PMID: 33365268 DOI: 10.3389/fonc.2020.562103] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
368 Gao Y, Mo W, Zhong L, Jia H, Xu Y, Zhang J, Xu X, Shen W, Wang F, Li T, Liu P, Zhang S. Downregulation of Ubiquitin Inhibits the Aggressive Phenotypes of Esophageal Squamous Cell Carcinoma. Technol Cancer Res Treat 2020;19:1533033820973282. [PMID: 33176591 DOI: 10.1177/1533033820973282] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
369 Du L, Zhao Z, Zheng R, Li H, Zhang S, Li R, Wei W, He J. Epidemiology of Thyroid Cancer: Incidence and Mortality in China, 2015. Front Oncol 2020;10:1702. [PMID: 33240801 DOI: 10.3389/fonc.2020.01702] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
370 Cui C, Yan X, Li B, Si L, Zhihong C, Sheng X, Lian B, Wang X, Mao L, Tang B, Zhou L, Bai X, Li S, Guo J. Real-world clinical outcomes of anticancer treatments and prognostic factors in patients with advanced melanoma in China. IJS Oncology 2021;5:97. [DOI: 10.1097/ij9.0000000000000097] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
371 Guo LW, Chen Q, Shen YC, Meng QC, Zheng LY, Wu Y, Cao XQ, Xu HF, Liu SZ, Sun XB, Qiao YL, Zhang SK. Evaluation of a Low-Dose Computed Tomography Lung Cancer Screening Program in Henan, China. JAMA Netw Open 2020;3:e2019039. [PMID: 33141158 DOI: 10.1001/jamanetworkopen.2020.19039] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
372 Sun Y, Gao J, Jing Z, Zhao Y, Sun Y, Zhao X. PURα Promotes the Transcriptional Activation of PCK2 in Oesophageal Squamous Cell Carcinoma Cells. Genes (Basel) 2020;11:E1301. [PMID: 33142842 DOI: 10.3390/genes11111301] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
373 Qiu G, Jin Z, Chen X, Huang J. Interpretation of guidelines for the diagnosis and treatment of primary liver cancer (2019 edition) in China. Glob Health Med. 2020;2:306-311. [PMID: 33330825 DOI: 10.35772/ghm.2020.01051] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
374 Zhai Z, Zhu ZY, Cong XL, Han BL, Gao JL, Yin X, Zhang Y, Lou SH, Fang TY, Wang YM, Li CF, Yu XF, Ma Y, Xue YW. Changing trends of clinicopathologic features and survival duration after surgery for gastric cancer in Northeast China. World J Gastrointest Oncol 2020; 12(10): 1119-1132 [PMID: 33133381 DOI: 10.4251/wjgo.v12.i10.1119] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
375 Yang Y, Ma Y, Xiang X, Xing P, Wu Y, Zhang L, Tian Y. The prognostic value of the lymph node ratio for local advanced gastric cancer patients with intensity-modulated radiation therapy and concurrent chemotherapy after radical gastrectomy in China. Radiat Oncol 2020;15:237. [PMID: 33054848 DOI: 10.1186/s13014-020-01687-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
376 Oudkerk M, Liu S, Heuvelmans MA, Walter JE, Field JK. Lung cancer LDCT screening and mortality reduction - evidence, pitfalls and future perspectives. Nat Rev Clin Oncol 2021;18:135-51. [PMID: 33046839 DOI: 10.1038/s41571-020-00432-6] [Cited by in Crossref: 85] [Cited by in F6Publishing: 99] [Article Influence: 28.3] [Reference Citation Analysis]
377 Xiao W, Liang H, Zhang H, Jia R, Yang Y, Wang Y, Tang P, Yu Z. Ratio between negative and positive lymph nodes is a novel prognostic indicator for patients with esophageal cancer: A Surveillance, Epidemiology and End Results database analysis. Thorac Cancer 2020;11:3490-500. [PMID: 33034409 DOI: 10.1111/1759-7714.13688] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
378 Liu J, Wang Y, Yu Y. Meta-analysis reveals an association between acute pancreatitis and the risk of pancreatic cancer. World J Clin Cases 2020; 8(19): 4416-4430 [PMID: 33083401 DOI: 10.12998/wjcc.v8.i19.4416] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
379 Hu J, Jiao X, Zhu L, Guo H, Wu Y. Establishment and verification of the nomogram that predicts the 3-year recurrence risk of epithelial ovarian carcinoma. BMC Cancer 2020;20:938. [PMID: 32993522 DOI: 10.1186/s12885-020-07402-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
380 Liu Y, Lai F, Long J, Peng S, Wang H, Zhou Q, Li B, Su L, Gan L, Shi Y, Lv W, Li Y, Cheng K, Xiao H. Screening and the epidemic of thyroid cancer in China: An analysis of national representative inpatient and commercial insurance databases. Int J Cancer 2021;148:1106-14. [PMID: 32930403 DOI: 10.1002/ijc.33298] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
381 Wang X, Zhang Y, Yang N, He H, Tao X, Kou C, Jiang J. Evaluation of the Combined Application of AFP, AFP-L3%, and DCP for Hepatocellular Carcinoma Diagnosis: A Meta-analysis. Biomed Res Int 2020;2020:5087643. [PMID: 33015170 DOI: 10.1155/2020/5087643] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
382 Xiao HF, Yan SP, Li JG, Shi ZH, Zou YH, Xu KK, Liao XZ. Development and external validation of a nomogram to predict the risk of Upper gastrointestinal precancerous lesions in a non-high-incidence area. Cancer Med 2020;9:8722-32. [PMID: 32937009 DOI: 10.1002/cam4.3462] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
383 Kong F, Jin M, Cao D, Jia Z, Liu Y, Jiang J. Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinoma. PeerJ 2020;8:e9949. [PMID: 32995093 DOI: 10.7717/peerj.9949] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
384 Yang J, Liu X, Cao S, Dong X, Rao S, Cai K. Understanding Esophageal Cancer: The Challenges and Opportunities for the Next Decade. Front Oncol 2020;10:1727. [PMID: 33014854 DOI: 10.3389/fonc.2020.01727] [Cited by in Crossref: 36] [Cited by in F6Publishing: 43] [Article Influence: 12.0] [Reference Citation Analysis]
385 Wang Y, Ren F, Song Z, Wang X, Ma X. Multiomics profile and prognostic gene signature of m6A regulators in uterine corpus endometrial carcinoma. J Cancer 2020;11:6390-401. [PMID: 33033522 DOI: 10.7150/jca.46386] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
386 Zheng L, Zhang B, He X, Cao G, Li Y, Cai K, Yang B, Wu Y. A New Fusion Peptide Targeting Pancreatic Cancer and Inhibiting Tumor Growth. Onco Targets Ther 2020;13:7865-75. [PMID: 32884283 DOI: 10.2147/OTT.S246969] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
387 Gao J, Han F, Jin Y, Wang X, Zhang J. A Radiomics Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma. Front Oncol. 2020;10:1654. [PMID: 32974205 DOI: 10.3389/fonc.2020.01654] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
388 He Y, Liang D, Du L, Guo T, Liu Y, Sun X, Wang N, Zhang M, Wei K, Shan B, Chen W. Clinical characteristics and survival of 5283 esophageal cancer patients: A multicenter study from eighteen hospitals across six regions in China. Cancer Commun (Lond) 2020;40:531-44. [PMID: 32845581 DOI: 10.1002/cac2.12087] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 6.7] [Reference Citation Analysis]
389 Guan Y, Ren M, Guo D, He Y. [Research Progress on Lung Cancer Screening]. Zhongguo Fei Ai Za Zhi 2020;23:954-60. [PMID: 32819054 DOI: 10.3779/j.issn.1009-3419.2020.101.37] [Reference Citation Analysis]
390 Wang G, Li G, Wu J, Song P. Analysis of prognostic factors for Tis-2N0M0 early glottic cancer with different treatment methods. Braz J Otorhinolaryngol 2020:S1808-8694(20)30113-0. [PMID: 32830100 DOI: 10.1016/j.bjorl.2020.06.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
391 Zhao W, Wang M, Wang C, Liu Y, Liu H, Luo S. RACGAP1 is transcriptionally regulated by E2F3, and its depletion leads to mitotic catastrophe in esophageal squamous cell carcinoma. Ann Transl Med 2020;8:950. [PMID: 32953750 DOI: 10.21037/atm-20-2901] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
392 Chen QY, Liu ZY, Zhong Q, Xie JW, Wang JB, Lin JX, Lu J, Cao LL, Lin M, Tu RH, Huang ZN, Lin JL, Zheng HL, Li P, Zheng CH, Huang CM. Clinical Impact of Delayed Initiation of Adjuvant Chemotherapy Among Patients With Stage II/III Gastric Cancer: Can We Do Better? Front Oncol 2020;10:1149. [PMID: 32850326 DOI: 10.3389/fonc.2020.01149] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
393 Tian Q, Qin L, Zhu W, Xiong S, Wu B. Analysis of factors contributing to postoperative body weight change in patients with gastric cancer: based on generalized estimation equation. PeerJ 2020;8:e9390. [PMID: 32728490 DOI: 10.7717/peerj.9390] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
394 Xi Y, Dong W, Qiao L, Han K, Chen W, Wang W. Trends in incidence and mortality of esophageal cancer in Inner Mongolia, 2010-2015. Thorac Cancer 2020;11:2440-8. [PMID: 32716130 DOI: 10.1111/1759-7714.13552] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
395 Dong D, Shen G, Da Y, Zhou M, Yang G, Yuan M, Chen R. Successful Treatment of Patients with Refractory High-Grade Serous Ovarian Cancer with GOPC-ROS1 Fusion Using Crizotinib: A Case Report. Oncologist 2020;25:e1720-4. [PMID: 32652753 DOI: 10.1634/theoncologist.2019-0609] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
396 Zeng Z, Yang B, Liao ZY. Current progress and prospect of immune checkpoint inhibitors in hepatocellular carcinoma. Oncol Lett 2020;20:45. [PMID: 32802167 DOI: 10.3892/ol.2020.11909] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
397 Liu X, Zhou M, Wang F, Mubarik S, Wang Y, Meng R, Shi F, Wen H, Yu C. Secular Trend of Cancer Death and Incidence in 29 Cancer Groups in China, 1990-2017: A Joinpoint and Age-Period-Cohort Analysis. Cancer Manag Res 2020;12:6221-38. [PMID: 32801868 DOI: 10.2147/CMAR.S247648] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
398 Zhang ZF, Huang TJ, Zhang XK, Xie YJ, Lin ST, Luo FF, Meng DF, Hu H, Wang J, Peng LX, Qian CN, Cheng C, Huang BJ. AKR1C2 acts as a targetable oncogene in esophageal squamous cell carcinoma via activating PI3K/AKT signaling pathway. J Cell Mol Med 2020;24:9999-10012. [PMID: 32678482 DOI: 10.1111/jcmm.15604] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
399 Xin J, Wu Y, Wang X, Li S, Chu H, Wang M, Du M, Zhang Z. A transcriptomic study for identifying cardia- and non-cardia-specific gastric cancer prognostic factors using genetic algorithm-based methods. J Cell Mol Med 2020;24:9457-65. [PMID: 32649057 DOI: 10.1111/jcmm.15618] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
400 Shi J, Zhang Y, Wang J, Li J, Li Z. Anlotinib Combined With Chemoradiotherapy Exhibits Significant Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma. Front Oncol 2020;10:995. [PMID: 32754439 DOI: 10.3389/fonc.2020.00995] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
401 Hu C, Li M. In advanced pancreatic cancer: The value and significance of interventional therapy. J Interv Med 2020;3:118-21. [PMID: 34805920 DOI: 10.1016/j.jimed.2020.07.002] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
402 Xu QL, Li H, Zhu YJ, Xu G. The treatments and postoperative complications of esophageal cancer: a review. J Cardiothorac Surg. 2020;15:163. [PMID: 32631428 DOI: 10.1186/s13019-020-01202-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
403 Cheng ASK, Liu X, Ng PHF, Kwok CTT, Zeng Y, Feuerstein M. Breast cancer application protocol: a randomised controlled trial to evaluate a self-management app for breast cancer survivors. BMJ Open 2020;10:e034655. [PMID: 32624468 DOI: 10.1136/bmjopen-2019-034655] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
404 Shi F, Xiao S, Miller KB, Zhao Y, Li Y, Gao Y, Chang H, Song Q, Qu C. Interactive Effects of PD-L1 Expression in Tumor and Immune Cells on Prognosis of Esophageal Squamous Cell Carcinoma: A One-Center Retrospective Cohort Study. Onco Targets Ther 2020;13:6565-72. [PMID: 32694918 DOI: 10.2147/OTT.S258332] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
405 Arnold M, Abnet CC, Neale RE, Vignat J, Giovannucci EL, McGlynn KA, Bray F. Global Burden of 5 Major Types of Gastrointestinal Cancer. Gastroenterology 2020;159:335-349.e15. [PMID: 32247694 DOI: 10.1053/j.gastro.2020.02.068] [Cited by in Crossref: 486] [Cited by in F6Publishing: 498] [Article Influence: 162.0] [Reference Citation Analysis]
406 Wei WQ, Hao CQ, Guan CT, Song GH, Wang M, Zhao DL, Li BY, Bai WL, Hou PY, Wang JW, Jin GL, Lei FH, Li XQ, Xue LY, Wang GQ, Abnet CC, Taylor PR, Dawsey SM, Qiao YL. Esophageal Histological Precursor Lesions and Subsequent 8.5-Year Cancer Risk in a Population-Based Prospective Study in China. Am J Gastroenterol 2020;115:1036-44. [PMID: 32618654 DOI: 10.14309/ajg.0000000000000640] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
407 Du R, Huang C, Chen H, Liu K, Xiang P, Yao N, Yang L, Zhou L, Wu Q, Zheng Y, Xin M, Dong Z, Li X. SDCBP/MDA-9/syntenin phosphorylation by AURKA promotes esophageal squamous cell carcinoma progression through the EGFR-PI3K-Akt signaling pathway. Oncogene 2020;39:5405-19. [PMID: 32572158 DOI: 10.1038/s41388-020-1369-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
408 Liu M, Liu X, Liu S, Xiao F, Guo E, Qin X, Wu L, Liang Q, Liang Z, Li K, Zhang D, Yang Y, Luo X, Lei L, Tan JHJ, Yin F, Zeng X. Big Data-Based Identification of Multi-Gene Prognostic Signatures in Liver Cancer. Front Oncol 2020;10:847. [PMID: 32547951 DOI: 10.3389/fonc.2020.00847] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
409 Ouyang D, Yang P, Cai J, Sun S, Wang Z. Comprehensive analysis of prognostic alternative splicing signature in cervical cancer. Cancer Cell Int 2020;20:221. [PMID: 32528230 DOI: 10.1186/s12935-020-01299-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
410 Wang J, Xu C, Cheng Q, Zhao J, Wu S, Li W, Ma W, Liu C, Jiang X. RNA Sequencing Revealed Signals of Evolution From Gallbladder Stone to Gallbladder Carcinoma. Front Oncol 2020;10:823. [PMID: 32547950 DOI: 10.3389/fonc.2020.00823] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
411 Han L, Li W, Li Y, Wen W, Yao Y, Wang Y. With High-Risk Factors, Total Thyroidectomy is Preferred for Thyroid Cancer. Cancer Manag Res 2020;12:3713-9. [PMID: 32547207 DOI: 10.2147/CMAR.S249324] [Reference Citation Analysis]
412 Ye H, Zhou L, Jin H, Chen Y, Cheng D, Jiang Y. Sorafenib-Loaded Long-Circulating Nanoliposomes for Liver Cancer Therapy. Biomed Res Int 2020;2020:1351046. [PMID: 32461962 DOI: 10.1155/2020/1351046] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
413 Cao M, Li H, Sun D, Chen W. Cancer burden of major cancers in China: A need for sustainable actions. Cancer Commun (Lond) 2020;40:205-10. [PMID: 32359212 DOI: 10.1002/cac2.12025] [Cited by in Crossref: 118] [Cited by in F6Publishing: 127] [Article Influence: 39.3] [Reference Citation Analysis]
414 Tang X, Chen S, Sui Q, Li X, Liu Z, Zhu F, Ding J, Yao Y, Jiang B, He Y. Response to nivolumab combining radiotherapy and nimotuzumab in metastatic oral squamous cell carcinoma patient with strong PD-L1 expression: a case report. Ann Transl Med 2020;8:402. [PMID: 32355846 DOI: 10.21037/atm.2020.02.96] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
415 Li F, Li X, Guo C, Xu R, Li F, Pan Y, Liu M, Liu Z, Shi C, Wang H, Wang M, Tian H, Liu F, Liu Y, Li J, Cai H, Yang L, He Z, Ke Y. Estimation of Cost for Endoscopic Screening for Esophageal Cancer in a High-Risk Population in Rural China: Results from a Population-Level Randomized Controlled Trial. Pharmacoeconomics 2019;37:819-27. [PMID: 30809788 DOI: 10.1007/s40273-019-00766-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
416 Jia M, Lin X, Zhou X, Yan H, Chen Y, Liu P, Bao L, Li A, Basu P, Qiao Y, Sankaranarayanan R. Diagnostic performance of automated breast ultrasound and handheld ultrasound in women with dense breasts. Breast Cancer Res Treat 2020;181:589-97. [PMID: 32338323 DOI: 10.1007/s10549-020-05625-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
417 Liu Y, Zhao G, Miao J, Li H, Ma Y, Liu X, Li S, Zhu Y, Xiong S, Zheng M, Fei S. Performance Comparison Between Plasma and Stool Methylated SEPT9 Tests for Detecting Colorectal Cancer. Front Genet 2020;11:324. [PMID: 32373158 DOI: 10.3389/fgene.2020.00324] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
418 Liu W, Ji X, Song Y, Wang X, Zheng W, Lin N, Tu M, Xie Y, Ping L, Ying Z, Zhang C, Deng L, Wu M, Feng F, Leng X, Sun Y, Du T, Zhu J. Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades. Cancer Med 2020;9:3765-74. [PMID: 32281275 DOI: 10.1002/cam4.3037] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
419 Zhu XD, Tang ZY, Sun HC. Targeting angiogenesis for liver cancer: Past, present, and future. Genes Dis 2020;7:328-35. [PMID: 32884987 DOI: 10.1016/j.gendis.2020.03.010] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 10.3] [Reference Citation Analysis]
420 Yan R, Yu J, Tanimoto T, Ozaki A, Lu X, Che B, Zhang Y, Chen P, Wang J. The relationship between sexual activity and sexual attitudes among breast cancer survivors in China. Cancer Med 2020;9:3425-36. [PMID: 32207884 DOI: 10.1002/cam4.2874] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
421 Wei MN, Su Z, Wang JN, Gonzalez Mendez MJ, Yu XY, Liang H, Zhou QH, Fan YG, Qiao YL. Performance of lung cancer screening with low-dose CT in Gejiu, Yunnan: A population-based, screening cohort study. Thorac Cancer 2020;11:1224-32. [PMID: 32196998 DOI: 10.1111/1759-7714.13379] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
422 Xu W, Li R, Liu F. Novel Prognostic Nomograms for Predicting Early and Late Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy. Cancer Manag Res. 2020;12:1693-1712. [PMID: 32214844 DOI: 10.2147/cmar.s241959] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
423 Li J, Pang H, Sun Z, Zhao L, Bai C. Health status of middle-aged and older cancer survivors: a nationwide cross-sectional study from the China Health and Retirement Longitudinal Study (CHARLS). Ann Transl Med 2020;8:183. [PMID: 32309330 DOI: 10.21037/atm.2020.01.105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
424 Cheng B, Xiong S, Li C, Liang H, Zhao Y, Li J, Shi J, Ou L, Chen Z, Liang P, Liang W, He J. An annual review of the remarkable advances in lung cancer clinical research in 2019. J Thorac Dis 2020;12:1056-69. [PMID: 32274174 DOI: 10.21037/jtd.2020.03.11] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
425 Zhu J. [Thoughts on autologous hematopoietic stem cell transplantation and mobilization in Chinese patients with non Hodgkin's lymphoma]. Zhonghua Xue Ye Xue Za Zhi 2020;41:1-4. [PMID: 32023746 DOI: 10.3760/cma.j.issn.0253-2727.2020.01.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
426 Diao Y, Qian J, Liu Y, Zhou Y, Wang Y, Ma H, Wang X, Luo R, Wagner A, Sun J, Liu Y. How government insurance coverage changed the utilization and affordability of expensive targeted anti-cancer medicines in China: an interrupted time-series study. J Glob Health 2019;9:020702. [PMID: 31673344 DOI: 10.7189/jogh.09.020702] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
427 Bo X, Wang J, Wang C, Nan L, Gao Z, Xin Y, Li M, Shen S, Liu H, Ni X, Suo T, Zhang D, Lu P, Wang Y, Liu H. High infiltration of mast cells is associated with improved response to adjuvant chemotherapy in gallbladder cancer. Cancer Sci 2020;111:817-25. [PMID: 31925976 DOI: 10.1111/cas.14302] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
428 Rana N, Gosain R, Lemini R, Wang C, Gabriel E, Mohammed T, Siromoni B, Mukherjee S. Socio-Demographic Disparities in Gastric Adenocarcinoma: A Population-Based Study. Cancers (Basel) 2020;12:E157. [PMID: 31936436 DOI: 10.3390/cancers12010157] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
429 Hassanipour S, Delam H, Arab-Zozani M, Abdzadeh E, Hosseini SA, Nikbakht HA, Malakoutikhah M, Ashoobi MT, Fathalipour M, Salehiniya H, Riahi S. Survival Rate of Prostate Cancer in Asian Countries: A Systematic Review and Meta-Analysis. Ann Glob Health 2020;86:2. [PMID: 31976303 DOI: 10.5334/aogh.2607] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
430 He S, Li H, Cao M, Sun D, Lei L, Li N, Peng J, Chen W. Trends and risk factors of lung cancer in China. Chin J Cancer Res 2020;32:683-94. [PMID: 33446992 DOI: 10.21147/j.issn.1000-9604.2020.06.02] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
431 Tan L, Tang H. Chinese Experiences of the Treatment of Esophageal Squamous Cell Carcinoma. Esophageal Squamous Cell Carcinoma 2020. [DOI: 10.1007/978-981-15-4190-2_20] [Reference Citation Analysis]
432 Li M, Shao D, Zhou J, Gu J, Qin J, Chen W, Wei W. Signatures within esophageal microbiota with progression of esophageal squamous cell carcinoma. Chin J Cancer Res 2020;32:755-67. [PMID: 33446998 DOI: 10.21147/j.issn.1000-9604.2020.06.09] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
433 Wang Z, Yang L, Liu S, Li H, Zhang X, Wang N, Ji J. Effects of insurance status on long-term survival among non-small cell lung cancer (NSCLC) patients in Beijing, China: A population-based study. Chin J Cancer Res 2020;32:596-604. [PMID: 33223754 DOI: 10.21147/j.issn.1000-9604.2020.05.04] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
434 Cheng G, He L. Dr. Pecker: A Deep Learning-Based Computer-Aided Diagnosis System in Medical Imaging. Intelligent Systems Reference Library 2020. [DOI: 10.1007/978-3-030-32606-7_12] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
435 Luo W, Tao J, Zheng L, Zhang T. Current epidemiology of pancreatic cancer: Challenges and opportunities. Chin J Cancer Res. 2020;32:705-719. [PMID: 33446994 DOI: 10.21147/j.issn.1000-9604.2020.06.04] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
436 Ma X, Cai W. Pancreatectomy with Other Organ Resection. Surgical Atlas of Pancreatic Cancer 2020. [DOI: 10.1007/978-981-32-9864-4_11] [Reference Citation Analysis]
437 Yang L, Ying X, Liu S, Lyu G, Xu Z, Zhang X, Li H, Li Q, Wang N, Ji J. Gastric cancer: Epidemiology, risk factors and prevention strategies. Chin J Cancer Res. 2020;32:695-704. [PMID: 33446993 DOI: 10.21147/j.issn.1000-9604.2020.06.03] [Cited by in Crossref: 38] [Cited by in F6Publishing: 54] [Article Influence: 12.7] [Reference Citation Analysis]
438 Cheng X, Jiang Z, Sun Q, Zhang J. Memory-Efficient Cascade 3D U-Net for Brain Tumor Segmentation. Brainlesion: Glioma, Multiple Sclerosis, Stroke and Traumatic Brain Injuries 2020. [DOI: 10.1007/978-3-030-46640-4_23] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
439 Ge J, Wang J, Wang H, Jiang X, Liao Q, Gong Q, Mo Y, Li X, Li G, Xiong W, Zhao J, Zeng Z. The BRAF V600E mutation is a predictor of the effect of radioiodine therapy in papillary thyroid cancer. J Cancer 2020;11:932-9. [PMID: 31949496 DOI: 10.7150/jca.33105] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 10.3] [Reference Citation Analysis]
440 Yang Y, Han Z, Li X, Huang A, Shi J, Gu J. Epidemiology and risk factors of colorectal cancer in China. Chin J Cancer Res 2020;32:729-41. [PMID: 33446996 DOI: 10.21147/j.issn.1000-9604.2020.06.06] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 9.0] [Reference Citation Analysis]
441 Cao M, Li H, Sun D, Lei L, Ren J, Shi J, Li N, Peng J, Chen W. Classifying risk level of gastric cancer: Evaluation of questionnaire-based prediction model. Chin J Cancer Res 2020;32:605-13. [PMID: 33223755 DOI: 10.21147/j.issn.1000-9604.2020.05.05] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
442 Zang R, Wang X, Jin R, Lei Y, Huang J, Liu C, Zheng S, Zhou F, Wu Q, Sun N, Gao S, He J. Translational value of IDH1 and DNA methylation biomarkers in diagnosing lung cancers: a novel diagnostic panel of stage and histology-specificity. J Transl Med 2019;17:430. [PMID: 31888670 DOI: 10.1186/s12967-019-2117-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
443 Cen X, Wang D, Sun W, Cao L, Zhang Z, Wang B, Chen W. The trends of mortality and years of life lost of cancers in urban and rural areas in China, 1990-2017. Cancer Med 2020;9:1562-71. [PMID: 31873982 DOI: 10.1002/cam4.2765] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
444 Huang L, Cai Y, Luo Y, Xiong D, Hou Z, Lv J, Zeng F, Yang Y, Cheng X. JAZF1 Suppresses Papillary Thyroid Carcinoma Cell Proliferation and Facilitates Apoptosis via Regulating TAK1/NF-κB Pathways. Onco Targets Ther 2019;12:10501-14. [PMID: 31819531 DOI: 10.2147/OTT.S230597] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
445 Liu F, Zhao J, Li C, Wu Y, Song W, Guo T, Chen S, Cai S, Huang D, Xu Y. The unique prognostic characteristics of tumor deposits in colorectal cancer patients. Ann Transl Med 2019;7:769. [PMID: 32042785 DOI: 10.21037/atm.2019.11.69] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
446 Zhao L, Li J, Bai C, Nie Y, Lin G. Multi-Modality Treatment for Patients With Metastatic Gastric Cancer: A Real-World Study in China. Front Oncol 2019;9:1155. [PMID: 31737573 DOI: 10.3389/fonc.2019.01155] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
447 Zhu XD, Sun HC. Emerging agents and regimens for hepatocellular carcinoma. J Hematol Oncol. 2019;12:110. [PMID: 31655607 DOI: 10.1186/s13045-019-0794-6] [Cited by in Crossref: 52] [Cited by in F6Publishing: 57] [Article Influence: 13.0] [Reference Citation Analysis]
448 Li K, Yang L, Li J, Guan C, Zhang S, Lao X, Ouyang D, Zheng G, Gao S, Wang D, Liang Y, Liao G. TGFβ induces stemness through non-canonical AKT-FOXO3a axis in oral squamous cell carcinoma. EBioMedicine 2019;48:70-80. [PMID: 31629677 DOI: 10.1016/j.ebiom.2019.09.027] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
449 Luo Y, Fu HY, Huang HL, Li HJ, Zhang J, Zhou YJ, Xu B, Wang J. Transcatheter arterial chemoembolization combined with microwave ablation for treatment of early liver cancer: Efficacy and prognostic factors for progression-free survival. Shijie Huaren Xiaohua Zazhi 2019; 27(19): 1201-1208 [DOI: 10.11569/wcjd.v27.i19.1201] [Reference Citation Analysis]
450 Tang Y, Ou Z, Yao Z, Qiao G. A case report of immune checkpoint inhibitor nivolumab combined with anti-angiogenesis agent anlotinib for advanced esophageal squamous cell carcinoma. Medicine (Baltimore) 2019;98:e17164. [PMID: 31577707 DOI: 10.1097/MD.0000000000017164] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
451 Yan T, Liu F, Gao J, Lu H, Cai J, Zhao X, Sun Y. Multilevel regulation of RUVBL2 expression predicts poor prognosis in hepatocellular carcinoma. Cancer Cell Int 2019;19:249. [PMID: 31572066 DOI: 10.1186/s12935-019-0974-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
452 Gao Y, Wang Z, Zhu Y, Zhu Q, Yang Y, Jin Y, Zhang F, Jiang L, Ye Y, Li H, Zhang Y, Liang H, Xiang S, Miao H, Liu Y, Hao Y. NOP2/Sun RNA methyltransferase 2 promotes tumor progression via its interacting partner RPL6 in gallbladder carcinoma. Cancer Sci 2019;110:3510-9. [PMID: 31487418 DOI: 10.1111/cas.14190] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 8.5] [Reference Citation Analysis]
453 Liu AQ, Vogtmann E, Shao DT, Abnet CC, Dou HY, Qin Y, Su Z, Wei WQ, Chen W. A Comparison of Biopsy and Mucosal Swab Specimens for Examining the Microbiota of Upper Gastrointestinal Carcinoma. Cancer Epidemiol Biomarkers Prev 2019;28:2030-7. [PMID: 31519703 DOI: 10.1158/1055-9965.EPI-18-1210] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
454 Li J, He J, Zhang Y, Huang Y, Liu S, Li Y, Xu J, He X, Lan Q. [Survival in Lung Cancer among Female Never-smokers in Rural Xuanwei 
and Fuyuan Counties in Eastern Yunnan Province, China]. Zhongguo Fei Ai Za Zhi 2019;22:477-87. [PMID: 31451137 DOI: 10.3779/j.issn.1009-3419.2019.08.01] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
455 Yang J, Wang Y, Liu K, Yang W, Zhang J. Risk Factors for Doxorubicin-Induced Serious Hyperglycaemia-Related Adverse Drug Reactions. Diabetes Ther 2019;10:1949-57. [PMID: 31428942 DOI: 10.1007/s13300-019-00677-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
456 Jiao X, Zhang S, Jiao J, Zhang T, Qu W, Muloye GM, Kong B, Zhang Q, Cui B. Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance. Clin Epigenetics 2019;11:120. [PMID: 31426855 DOI: 10.1186/s13148-019-0719-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 8.0] [Reference Citation Analysis]
457 Wang X, Kong C, Xu W, Yang S, Shi D, Zhang J, Du M, Wang S, Bai Y, Zhang T, Chen Z, Ma Z, Wang J, Dong G, Sun M, Yin R, Chen F. Decoding tumor mutation burden and driver mutations in early stage lung adenocarcinoma using CT-based radiomics signature. Thorac Cancer 2019;10:1904-12. [PMID: 31414580 DOI: 10.1111/1759-7714.13163] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
458 Zhao G, Li H, Yang Z, Wang Z, Xu M, Xiong S, Li S, Wu X, Liu X, Wang Z, Zhu Y, Ma Y, Fei S, Zheng M. Multiplex methylated DNA testing in plasma with high sensitivity and specificity for colorectal cancer screening. Cancer Med 2019;8:5619-28. [PMID: 31407497 DOI: 10.1002/cam4.2475] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 7.3] [Reference Citation Analysis]
459 Najberg M, Haji Mansor M, Boury F, Alvarez-Lorenzo C, Garcion E. Reversing the Tumor Target: Establishment of a Tumor Trap. Front Pharmacol 2019;10:887. [PMID: 31456685 DOI: 10.3389/fphar.2019.00887] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
460 Wang F, Mubarik S, Zhang Y, Wang L, Wang Y, Yu C, Li H. Long-Term Trends of Liver Cancer Incidence and Mortality in China 1990-2017: A Joinpoint and Age-Period-Cohort Analysis. Int J Environ Res Public Health 2019;16:E2878. [PMID: 31408961 DOI: 10.3390/ijerph16162878] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
461 Liu J, Han M, Huang H. Validation of the diagnostic efficiency of folate receptor-positive circulating tumor cells in lung cancers: a prospective observational study. Transl Cancer Res 2019;8:1242-8. [PMID: 35116866 DOI: 10.21037/tcr.2019.07.10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
462 Wang KL, Chen XL, Lei L, Li P, Hong LL, Huang XC, Mao WM, Mukaisho K, Ling ZQ. Validation study of susceptibility loci for esophageal squamous cell carcinoma identified by GWAS in a Han Chinese subgroup from Eastern China. J Cancer 2019;10:3624-31. [PMID: 31333779 DOI: 10.7150/jca.32810] [Reference Citation Analysis]
463 Wang X, Yang Y, Tan X, Mao X, Wei D, Yao Y, Jiang P, Mo D, Wang T, Yan F. Identification of tRNA-Derived Fragments Expression Profile in Breast Cancer Tissues. Curr Genomics 2019;20:199-213. [PMID: 31929727 DOI: 10.2174/1389202920666190326145459] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
464 Fu X, Li T, Dai Y, Li J. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma. BMC Cancer 2019;19:721. [PMID: 31331297 DOI: 10.1186/s12885-019-5940-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
465 Yang J, Zheng R, Liang M, Jia Y, Lin L, Geng J, Chen S, Li YX. Association of the Cumulative Dose of Radioactive Iodine Therapy With Overall Survival in Patients With Differentiated Thyroid Cancer and Pulmonary Metastases. Front Oncol 2019;9:558. [PMID: 31316914 DOI: 10.3389/fonc.2019.00558] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
466 Hou H, Meng Z, Zhao X, Ding G, Sun M, Wang W, Wang Y. Survival of Esophageal Cancer in China: A Pooled Analysis on Hospital-Based Studies From 2000 to 2018. Front Oncol 2019;9:548. [PMID: 31316913 DOI: 10.3389/fonc.2019.00548] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
467 Liu T, Qin Y, Li J, Xu R, Xu J, Yang S, Qin S, Bai Y, Wu C, Mao Y, Wu H, Ge Y, Shen L. Pertuzumab in combination with trastuzumab and chemotherapy for Chinese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subpopulation analysis of the JACOB trial. Cancer Commun (Lond) 2019;39:38. [PMID: 31234927 DOI: 10.1186/s40880-019-0384-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
468 Chen J, Jiang D, Huang F. [Advances of the Correlation between Driver Gene Status and Immunotherapy 
in Non-small Cell Lung Cancer]. Zhongguo Fei Ai Za Zhi 2019;22:233-8. [PMID: 31014442 DOI: 10.3779/j.issn.1009-3419.2019.04.06] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
469 Zhao L, Huang H, Zhao D, Wang C, Tian Y, Yuan X, Ma F, Ren H, Zhao Y, Aimaiti S, Zhang S, Zhou H, Wang T, Wang N, Sun Y, Bai X, Chen Y. Clinicopathological Characteristics and Prognosis of Proximal and Distal Gastric Cancer during 1997-2017 in China National Cancer Center. J Oncol 2019;2019:9784039. [PMID: 31312217 DOI: 10.1155/2019/9784039] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
470 Zhang Z, Liu X, Huang R, Liu X, Liang Z, Liu T. Upregulation of nucleoprotein AHNAK is associated with poor outcome of pancreatic ductal adenocarcinoma prognosis via mediating epithelial-mesenchymal transition. J Cancer 2019;10:3860-70. [PMID: 31333803 DOI: 10.7150/jca.31291] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
471 Xiao M, Cui S, Zhang L, Yu T, Zhang G, Zhang Q, Li L, Cai Y, Jin C, Yang J, Wu S, Lu X. AC138128.1 an Intronic lncRNA originating from ERCC1 Implies a Potential Application in Lung Cancer Treatment. J Cancer 2019;10:3608-17. [PMID: 31333777 DOI: 10.7150/jca.31832] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
472 Huang X, Hong C, Peng Y, Yang S, Huang L, Liu C, Chen L, Chu L, Xu L, Xu Y. The Diagnostic Value of Serum IGFBP7 in Patients with Esophageal Squamous Cell Carcinoma. J Cancer 2019;10:2687-93. [PMID: 31258777 DOI: 10.7150/jca.32393] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
473 Li H, Zhang SR, Xu HX, Wang WQ, Li S, Li TJ, Ni QX, Yu XJ, Liu L, Wu CT. SRPX2 and RAB31 are effective prognostic biomarkers in pancreatic cancer. J Cancer 2019;10:2670-8. [PMID: 31258775 DOI: 10.7150/jca.32072] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
474 Liu B, Lao X, Feng Y, Liu J, Jiao M, Zhao M, Wang J, Zhang X, Liu J, Qi X, Liu H, Chen R, Wu Q, Hao Y. Cancer prevalence among the rural poverty-stricken population in Northeast China. Cancer Manag Res 2019;11:5101-12. [PMID: 31213921 DOI: 10.2147/CMAR.S205867] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
475 Li L, Liu C, Cai X, Yu H, Zeng X, Sui M, Zheng E, Li Y, Xu J, Zhou J, Huang W. Validity and reliability of the EQ-5D-5 L in family caregivers of leukemia patients. BMC Cancer 2019;19:522. [PMID: 31146707 DOI: 10.1186/s12885-019-5721-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
476 Zheng Q, Fu X, Jiang J, Zhang N, Zou L, Wang W, Ding M, Chen H. Umbilical Cord Mesenchymal Stem Cell Transplantation Prevents Chemotherapy-Induced Ovarian Failure via the NGF/TrkA Pathway in Rats. Biomed Res Int 2019;2019:6539294. [PMID: 31240219 DOI: 10.1155/2019/6539294] [Cited by in Crossref: 13] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
477 Liu Y, Gao Y, Chen XJ, Hua H. [DNA cytometry of exfoliated cells in the diagnosis of oral potential malignant disorders]. Beijing Da Xue Xue Bao Yi Xue Ban 2019;51:16-20. [PMID: 30773538 DOI: 10.19723/j.issn.1671-167X.2019.01.004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
478 Feng RM, Zong YN, Cao SM, Xu RH. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics? Cancer Commun (Lond). 2019;39:22. [PMID: 31030667 DOI: 10.1186/s40880-019-0368-6] [Cited by in Crossref: 733] [Cited by in F6Publishing: 834] [Article Influence: 183.3] [Reference Citation Analysis]
479 Feng RM, Zong YN, Cao SM, Xu RH. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics? Cancer Commun (Lond) 2019;39:22. [PMID: 31030667 DOI: 10.1186/s40880-019-0368-6] [Cited by in Crossref: 544] [Cited by in F6Publishing: 4] [Article Influence: 136.0] [Reference Citation Analysis]
480 Zhang J, Wang J, Luan T, Zuo Y, Chen J, Zhang H, Ye Z, Wang H, Hai B. Deubiquitinase USP9X regulates the invasion of prostate cancer cells by regulating the ERK pathway and mitochondrial dynamics. Oncol Rep 2019;41:3292-304. [PMID: 31002345 DOI: 10.3892/or.2019.7131] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
481 Yin Z, Wang Y, Sun J, Huang Q, Liu J, He S, Han C, Wang S, Ding B, Yin J. Association of sociodemographic and oncological features with decision on implant-based versus autologous immediate postmastectomy breast reconstruction in Chinese patients. Cancer Med 2019;8:2223-32. [PMID: 30950238 DOI: 10.1002/cam4.2133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
482 Chen Y, Wang Z, Zhao G, Sun C, Ma Y, Zhang L, Zheng M, Li H. Performance of a Novel Blood-Based Early Colorectal Cancer Screening Assay in Remaining Serum after the Blood Biochemical Test. Dis Markers. 2019;2019:5232780. [PMID: 31089394 DOI: 10.1155/2019/5232780] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
483 Li Z, Pan Z, Zhang L, He R, Jiang S, Xu C, Lu F, Zhang P, Li B. End-of-life cost and its determinants for cancer patients in urban China: a population-based retrospective study. BMJ Open 2019;9:e026309. [PMID: 30898830 DOI: 10.1136/bmjopen-2018-026309] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
484 Liu W, Liu J, Song Y, Wang X, Zhou M, Wang L, Ma J, Zhu J; Union for China Leukemia Investigators of the Chinese Society of Clinical Oncology, Union for China Lymphoma Investigators of the Chinese Society of Clinical Oncology. Mortality of lymphoma and myeloma in China, 2004-2017: an observational study. J Hematol Oncol 2019;12:22. [PMID: 30832702 DOI: 10.1186/s13045-019-0706-9] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 9.0] [Reference Citation Analysis]
485 Zhao C, Gao F, Li Q, Liu Q, Lin X. The Distributional Characteristic and Growing Trend of Pancreatic Cancer in China. Pancreas 2019;48:309-14. [PMID: 30855427 DOI: 10.1097/MPA.0000000000001222] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
486 Jia ZF, Cao DH, Wu YH, Jin MS, Pan YC, Cao XY, Jiang J. Lethal-7-related polymorphisms are associated with susceptibility to and prognosis of gastric cancer. World J Gastroenterol 2019; 25(8): 1012-1023 [PMID: 30833806 DOI: 10.3748/wjg.v25.i8.1012] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
487 Han S, Huang T, Wu X, Wang X, Li W, Liu S, Yang W, Shi Q, Li H, Shi K, Hou F. Prognostic value of ALDH1 and Nestin in advanced cancer: a systematic meta-analysis with trial sequential analysis. Ther Adv Med Oncol 2019;11:1758835919830831. [PMID: 30833990 DOI: 10.1177/1758835919830831] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
488 Aziz N, Faraz M, Sherwani MA, Fatma T, Prasad R. Illuminating the Anticancerous Efficacy of a New Fungal Chassis for Silver Nanoparticle Synthesis. Front Chem 2019;7:65. [PMID: 30800654 DOI: 10.3389/fchem.2019.00065] [Cited by in Crossref: 114] [Cited by in F6Publishing: 114] [Article Influence: 28.5] [Reference Citation Analysis]
489 Xi L, Zhu J, Zhang H, Muktiali M, Xu C, Wu A. Epidemiological Trends in Gastrointestinal Cancers in China: An Ecological Study. Dig Dis Sci 2019;64:532-43. [PMID: 30350242 DOI: 10.1007/s10620-018-5335-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
490 Wang Y, Chen H, Ju K, Kopp MF, Johnson SB, Farrell KK, Yuan G, Ataman LM, Zheng W, Woodruff TK, Xiao S. Female oncofertility attitude and knowledge: a survey of reproductive health professionals in Shanghai, China. Future Oncol 2019;15:371-9. [PMID: 30620219 DOI: 10.2217/fon-2018-0428] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
491 Wang M, Hao C, Xie S, Ma S, Ma Q, Zheng R, Chen R, Li X, Wei W. Efficacy of endoscopic treatment on patients with severe dysplasia/carcinoma in situ of esophageal squamous cell carcinoma: A prospective cohort study. Chin J Cancer Res 2019;31:357-65. [PMID: 31156306 DOI: 10.21147/j.issn.1000-9604.2019.02.10] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
492 He Y, Li D, Shan B, Liang D, Shi J, Chen W, He J. Incidence and mortality of esophagus cancer in China, 2008-2012. Chin J Cancer Res 2019;31:426-34. [PMID: 31354211 DOI: 10.21147/j.issn.1000-9604.2019.03.04] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
493 Jia S, Li H, Zeng H, Zheng R, Li J, Shi J, Yang Z, Cao M, Chen W. Association of cancer prevention awareness with esophageal cancer screening participation rates: Results from a population-based cancer screening program in rural China. Chin J Cancer Res 2019;31:601-8. [PMID: 31564803 DOI: 10.21147/j.issn.1000-9604.2019.04.04] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
494 Piazuelo MB, Riechelmann RP, Wilson KT, Algood HMS. Resolution of Gastric Cancer-Promoting Inflammation: A Novel Strategy for Anti-cancer Therapy. Curr Top Microbiol Immunol 2019;421:319-59. [PMID: 31123895 DOI: 10.1007/978-3-030-15138-6_13] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
495 Hu K, Kang N, Liu Y, Guo D, Jing W, Lu J, Tan T, Lv C, Deng Y, Long J, Wang R, Yu J. Proposed revision of N categories to the 8th edition of the AJCC-TNM staging system for non-surgical esophageal squamous cell cancer. Cancer Sci 2019;110:717-25. [PMID: 30467921 DOI: 10.1111/cas.13891] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
496 Bai Y, Liu ZS, Xiong JP, Xu WY, Lin JZ, Long JY, Miao F, Huang HC, Wan XS, Zhao HT. Nomogram to predict overall survival after gallbladder cancer resection in China. World J Gastroenterol 2018; 24(45): 5167-5178 [PMID: 30568393 DOI: 10.3748/wjg.v24.i45.5167] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
497 Chen T, Yang Z, Liu C, Wang L, Yang J, Chen L, Li W. Circ_0078767 suppresses non-small-cell lung cancer by protecting RASSF1A expression via sponging miR-330-3p. Cell Prolif 2019;52:e12548. [PMID: 30507050 DOI: 10.1111/cpr.12548] [Cited by in Crossref: 59] [Cited by in F6Publishing: 66] [Article Influence: 11.8] [Reference Citation Analysis]
498 Zheng G, Hou F. Cantharidin Triggers Apoptosis via ALB and PPP2R4 against Lung Cancer. 2018 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) 2018. [DOI: 10.1109/bibm.2018.8621576] [Reference Citation Analysis]
499 Cao M, Chen W. Epidemiology of lung cancer in China. Thorac Cancer 2019;10:3-7. [PMID: 30485694 DOI: 10.1111/1759-7714.12916] [Cited by in Crossref: 191] [Cited by in F6Publishing: 222] [Article Influence: 38.2] [Reference Citation Analysis]
500 McCormick PJ. Cancer Tsunami: Emerging Trends, Economic Burden, and Perioperative Implications. Curr Anesthesiol Rep 2018;8:348-54. [PMID: 31130826 DOI: 10.1007/s40140-018-0294-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
501 Yan R, Chen X, Gong X, Wang J, Yu J. The association of tooth loss, toothbrushing, and quality of life among cancer survivors. Cancer Med 2018;7:6374-84. [PMID: 30378280 DOI: 10.1002/cam4.1835] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
502 Xiang S, Wang Z, Ye Y, Zhang F, Li H, Yang Y, Miao H, Liang H, Zhang Y, Jiang L, Hu Y, Zheng L, Liu X, Liu Y. E2F1 and E2F7 differentially regulate KPNA2 to promote the development of gallbladder cancer. Oncogene 2019;38:1269-81. [PMID: 30254209 DOI: 10.1038/s41388-018-0494-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
503 Zheng R, Zeng H, Zhang S, Gu X, Sun K, Xia C, Yang Z, Li H, Chen W. The epidemiology of colorectal cancer in China. Global Health Journal 2018;2:8-20. [DOI: 10.1016/s2414-6447(19)30158-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
504 Ge Y, Zhang C, Xiao S, Liang L, Liao S, Xiang Y, Cao K, Chen H, Zhou Y. Identification of differentially expressed genes in cervical cancer by bioinformatics analysis. Oncol Lett 2018;16:2549-58. [PMID: 30013649 DOI: 10.3892/ol.2018.8953] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
505 Zheng R, Qu C, Zhang S, Zeng H, Sun K, Gu X, Xia C, Yang Z, Li H, Wei W, Chen W, He J. Liver cancer incidence and mortality in China: Temporal trends and projections to 2030. Chin J Cancer Res. 2018;30:571-579. [PMID: 30700925 DOI: 10.21147/j.issn.1000-9604.2018.06.01] [Cited by in Crossref: 119] [Cited by in F6Publishing: 143] [Article Influence: 23.8] [Reference Citation Analysis]